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Chapter I Introduction 
 
Hospital readmission is disruptive to patients and costly to healthcare systems. 
Unnecessary return to hospitals shortly after discharge has been increasingly perceived as 
a marker of the quality of care that patients receive during hospital admission (Chassin et 
al., 2010). About one in five Medicare fee-for-service beneficiaries, totaling over 2.3 
million patients, are rehospitalized within 30 days after discharge, incurring an annual 
cost of $17 billion, which constitutes nearly 20% of Medicare’s total payment (Jencks et 
al., 2009). 
However, it is reported by the Medicare Payment Advisory Commission (MedPAC) 
that about 75% of such readmissions can and should be avoided because they often result 
from a fragmented healthcare system that leaves discharged patients with preventable 
flaws such as hospital-acquired infections and other complications, poor planning for 
follow up care transitions, inadequate communication of discharge instructions, and 
failure to reconcile and coordinate medications (Medicare Payment Advisory 
Commission, 2007). Variations in both medical and surgical readmission rates by 
different hospitals and different geographic regions also indicate that some centers (or 
regions) perform better than others at containing readmission rates (Tsai et al., 2013; 
Jencks et al., 2009) Studies also show that the adjusted readmission rate in the US is 
among the highest ranking in comparison to European countries (Westert et al., 2002). 
Hospital readmission rates have been identified as a main measure of quality of care 
received by patients (Friedman, Basu, 2004) since they are happened due to such factors 
as premature discharging process or inadequate access to care. More importantly, it is 
found that rehospitalization causes an unfitting share of costs for inpatient hospital cares. 
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In 2009, (Jencks et al., 2009) reported that 19.6% of Medicare fee-for-service patients 
discharged from a hospital were readmitted within 30 days, 34.0% within 90 days, and 
more than half (56.1%) within one year of discharge, collectively accounting for $15 
billion of Medicare spending. And recently, based on Obama Care Rule (known as 
Patient Protection and Affordable Care Act or PPACA), about two-thirds (or 2,211) of 
U.S. hospitals have been penalized a cumulative $280 million (1%) in Medicare funds 
because of excess readmissions starting Oct. 1, 2012. This cut will grow to maximum of 
2% for the 2014 program year and 3% for 2015 (Fiegl, 2012). 
Generally, a readmission may be defined as a return hospitalization to a same (or 
different) acute care hospital following a prior acute care admission within a specified 
time interval. Although selection of a time interval can have an impact on rate of 
readmission, no standard time frame is used by all hospitals and various periods such as 
14 days (Reed at al., 1991) or 90–180 days (Benbassat et al., 1995) have been considered. 
Nevertheless, the Veteran Health Administration (VHA) defines readmission rate as a 
proportion of patients who were readmitted to the acute care wards of a hospital within 
30 days following the discharge with some exclusions such as patients died up to one day 
after discharge or patients with psychiatry, rehabilitation and hospice ward stays.  
Another issue which makes the hospital readmission analysis rather complicated 
comes out from of the fact that not all readmission can be grouped as preventable. 
Although several studies have tried to define preventable readmission, still no census 
exists on how to systematically separate those readmissions that might be avoidable and 
those that might not (Stone, Hoffman, 2010) It is also found that lots of patient 
characteristics such age, gender, race, financial condition and even illness type are 
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substantially related to patient risk of  readmission (Soeken, et al., 1991; Boutwell et al., 
2009). However there is still little support to effectively determine which patient factors 
result in a high risk of rehospitalization based on credible clinical criteria. And this issue 
is to be tackled in our research. 
Basically one part of related literature involves providing interventions programs to 
reduce avoidable readmissions without a supporting theoretical or mathematical 
methodology as mentioned in (Demir, E., et al., 2009). 
 In contrast, there are some methodological studies that explore the readmission 
process with the help of a mathematical and/or statistical modeling approach. For 
example, (Cotter et al., 2012) proposed a framework based on transition models to model 
the risk of readmission for chronic obstructive pulmonary disease (COPD) patients in 
UK. They also presented a method to come up with suitable choice of a time window 
which defines readmission. Another study of older UK inpatients showed that the 
internationally-accepted LACE index (Length of stay, Acuity of the admission, Charlston 
co-morbidity index score, and Emergency department visits within six months) is a poor 
tool for predicting 30-day readmission according to logistic regression analysis (Cotter et 
al., 2012). In addition, (Norouzzadeh, S., et al., 2011) presented a comparative study of 
three classification methods with respect to the conventional LACE score and their 
proposed weighted LACE score, and demonstrated the superiority of theirs with 
experimental results.  
In addition, effective October 2012, as directed by Patient Protection and Affordable 
Care Act (PPACA, also called Obamacare), the Centers for Medicare and Medicaid 
Services (CMS) started to cut reimbursement funds for hospitals that have excessive 
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30-day readmission rates for heart failure, myocardial infarction, and pneumonia patients. 
This included 2,213 US hospitals with approximately $280 million funds nationwide, 
which constitutes 1% of the total Medicare budget. Moreover, this cut will grow to 2% 
and 3% for FY 2014 and 2015, respectively. As a result, numerous intervention programs 
have been proposed by policymakers and healthcare organizations to reduce 
rehospitalizations and improve quality and access to care (Hansen et al., 2001). 
While it would be perfect to include all patients in a transitional care intervention, due 
to their resource intensive nature on one hand and hospital supplies constraints on the 
other, it is inevitable to target and deliver such efforts to those subgroups that are at 
greater risk. Nevertheless, identifying patients at increased risk of readmission is 
challenging and calls for advanced analytics tools that help to stratify risk into clinically 
relevant classes and provide information early enough during the hospitalization.  
Various methods have been proposed in recent years to predict hospital readmission 
but most of them do not yield acceptable predictive accuracy, or they are based on patient 
factors that are not typically collected during clinical care (Kansagara et al., 2011). 
Furthermore, a few methods have tried to distinguish avoidable readmission form all 
other types of readmissions (Walraven et aal., 2011), but it remains a disagreement how 
to systematically define and identify those readmissions that can be prevented based on 
credible clinical criteria. 
Another important aspect of readmission studies is related to the choice of timeframe 
used to count the number of readmissions. Although the CMS establish 30-day cutoff 
point for the three acute conditions (heart failure, myocardial infarction, and pneumonia), 
researchers have considered other periods from two weeks (Reed, Pearlman, Buchner, 
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1991) to 180 days (Benbassat, Taragin, 2000) for certain surgical and medical conditions. 
Moreover, with the new chronic and surgical conditions to be penalized in the next few 
years, questions regarding the suitability of the 30 day time window remain to be 
explored.  
1.2. Research background 
 
Hospital readmission is disruptive to patients and costly to healthcare systems. During 
FY 2003-04 near one-fifth of Medicare beneficiaries ̶ over 2.3 million patients ̶ were 
readmitted within 30 days of discharge, yielding to a cost of $17 billion, which is about 
20% of Medicare’s total payment. In 2005 the Medicare Payment Advisory Commission 
(MedPAC) reported that 17.6% of all-cause hospitalizations followed by readmissions in 
a 30-day period after discharge, 11.3% within 15 days, and 6.2% within 7 days. Studies 
also showed that adjusted readmission rate in US is among the highest rank in 
comparison to European countries (Westert et al., 2002).  
Further, readmission is found to associate with health service access and quality of 
care (Kangovi & Grande, 2011). Patients readmitted to hospitals may experience 
premature discharge planning, poor coordination of care, and even erroneous diagnosis. 
Researches also indicate that increased 30-day risk-standardized readmission rates are 
connected with lower patient satisfaction (Boulding et al., 2011). Nonetheless, a large 
proportion of readmissions is obviously planned and deemed appropriate especially when 
they are followed by procedures or surgeries. And to date, there is no consensus on how 
to systematically separate among “bad” readmissions and those that might be advisable. 
On the other hand, with publically reporting 30-day readmission rates, the Centers for 
Medicare and Medicaid Services (CMS) has begun comparing hospital’s performances 
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by their readmission rates on its Hospital Compare website. And as stipulated by §3025 
of the Patient Protection and Affordable Care Act (PPACA, known as Obama Care Rule), 
medical centers with high readmission rates for acute myocardial infarction (AMI), heart 
failure (HF), and pneumonia have lost 1% of their Medicare budget starting Oct. 1, 2012. 
Unfortunately this included 2,213 US hospitals with approximately $280 million funds 
nationwide, and the cut will grow up to 2 percent for FY 2014 and up to 3 percent for FY 
2015. As a result, about one-third of Michigan hospitals (55) were penalized near $14 
Million in FY 2013 (Russell & Eller, 2013). Therefore numerous intervention programs 
have been emerged by policymakers and health care practitioners in the past 5 years to 
decrease readmissions and improve the quality of patient care. 
Generally, a readmission (also referred to as re-hospitalization) is defined as a return 
hospitalization to a same (or different) care unit within a specific time interval, following 
a prior admission and discharge. Although selection of a time interval influences the rate 
of readmission, no standard time frame is yet adopted and various periods from 7 days to 
one year have been considered (Stone & Hoffman, 2010). Typically when it comes to 
acute care hospitalization, the calculation of readmission rate is adjusted with some 
exclusions. These may include admissions within 24 hours of discharge, patient stays 
with nursing home and rehabilitation wards, and patients died up to one day after 
discharge. 
From a systems engineering viewpoint, there are lots of factors that drive readmission 
problem and make its analysis rather complicated. First, various risk attributes contribute 
to patient likelihood of readmission and they come from different levels of health care 
such as patient’s level (age), provider’s level (years of experience), or even facility’s 
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level (bed supply) risk factors. Also these tend to be varied substantially by geographic 
area and at different points in time ̶ spatial and temporal variations (see Fig.1 and Fig.2). 
Second, although not all readmissions are avoidable, policy makers assert that some 
types of services and procedures have excessive readmission rates thus hospitalization 
costs could be declined a lot if a higher quality of care were brought to patients 
throughout hospital stays or post-discharge settings. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1 Rate of readmission between Oct. 1, 2003 and Sep. 30,  2004. 
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 Figure 2 2010 rate of 30-day readmission in Medicare beneficiaries  
 
In addition, different approaches of defining avoidable readmissions result in 
different rates of readmission and yet there is no agreement on a unified way of definition 
and also on strategies implemented to prevent such readmissions. Third, the time frame, 
which defines the readmission, is changed for different illness types and while this case 
has direct effects on computing the percentages of readmission, no systematic method is 
existed in the literature. Fourth, readmission depends directly on discharge organism in a 
health care system so the dynamics therein could affect or be affected by discharge 
changing aspects. At the same time, strategies addressing the readmission problem may 
involve a large part of organization such as operations, planning, and even finance 
department.  
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As mentioned, a number of intervention programs have been under way to reduce 
avoidable readmissions across the nation. Some commonly advocated strategies include 
patient education about their medications, patient-centered discharge instruction, follow-
up telephone calls, and post-discharge home visits. When designed by randomized 
controlled trials, such interventions were easily evaluated and found to be really effective 
as compared to observational studies in a variety of patient populations. (Bradley et al., 
2012; Hansen et al., 2011). However due to budget limitations, there is a need to mark 
patients with high risk of readmission who benefit the most from implementing such 
provisions. This is typically done using predictive models that either try to classify high-
risk patients with the help of learning algorithms, or produce a likelihood score for 
change of getting readmitted with some probability.  
The former class utilizes supervised and/or unsupervised approaches without any 
assumptions about the underlying mechanism that generates the data, while the latter 
basically uses statistical models with data assumed being stemmed from a given 
stochastic data model. Each class of methods has its own advantages and drawbacks in 
terms of misclassification errors as well as specific assumptions and computational 
difficulties they pose. Overall it is found that most such predictive models perform poorly 
in terms of discrimination power (Kansagara et al., 2011). Thus one part of the current 
study will be devoted to propose better prediction models that alleviate such pitfalls in the 
literature. Moreover, the existing methods cannot be directly applied in some specific 
circumstances within the readmission problem. Examples may include longitudinal 
observations when patient information is censored before the end of study period, 
	  	  
10	  
repeated measure data with imbalanced class problems, and multilevel competing risk 
models with time-dependent covariates.       
Apart from various predictive analytics that can be thought for the readmission 
problem, the literature also lacks an optimization framework to deal with operational 
costs and benefits that intervention programs can cause in a medical center. Such 
approaches would provide insights to determine better ways to operate 
admission/discharge activities and target business objectives of the health care system 
while satisfying some operational constraints. Thus another part of current study would 
pertain to developing a mathematical programming framework to optimally allocate 
intervention programs to patients most prone to readmission in a medical facility. 
In my research we will use Veteran Health Administration (VHA) database systems 
to aggregate required information from different health care levels such as patient 
demographic, general medical status, and also provider data. By doing this, my approach 
would better capture both patient-based and population-based variations of readmission.   
1.3. Research objective 
The key purposes of this research are listed as follows: 
1. Tackle the difficulties around the time frame that defines readmission. I seek to 
propose an approach based on phase-type distribution and continuous-time Markov 
chain to optimally define time interval for readmission (Predictive Analytics).  
2. Combine population-based and individual-based risk prediction models in order to 
capture the inherent variations of readmission caused from both patient population 
and single’s past history of readmission. By this, we provide reliable initial estimate 
of readmission for each patient based on characteristics of the population he/she 
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belongs to and then we can personalize it for one’s own behavior with incorporating 
risk factor changes over time (Predictive Analytics).  
3. Formulate the readmission problem within an optimization framework that 
dynamically uses predictions from 2 to find the best way of allocating the 
interventions to a set of patients. That way, by obtaining data in say weekly schedule 
we can analytically reflect migration of patients in and out of a hospital to the 
readmission intervention planning (Prescriptive Analytics).       
We plan to perform lots of descriptive analytics too by summarizing and plotting 
variables in the past and present VA datasets. This is particularly helpful to find basic 
questions about the patient populations under study: Are they rather old? What is the sex 
ratio among them? What types of diseases they are most prone to?   
Moreover, some research questions that I would like to address in this study are as 
follows: 
1. What patient characteristics contribute the most to the chance of being readmitted? 
Are provider or facility level factors related to the risk of readmission? Do 
readmission variations of any patient-level risk factors change at different providers 
or facilities? If these are the cases, at which levels of risk factors is the readmission 
rate higher? 
2. Are the patients more likely to be readmitted in the first week after discharge? What 
are the most frequent diagnoses that patients get readmitted after? Do the odds of 
readmission for those diagnoses change with patient demographic variables and 
timing of readmission? 
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3. How can we distinguish between advisable and preventable readmission in 
administrative data systematically? To what extent does preventability alter the true 
rate of readmission and hospital profiling method? 
4. What is the effect of intervention programs on reducing readmission rates? Does this 
effect vary among pre-discharge, bridging, and post-discharge interventions? Which 
type of intervention is most useful for VA patients diagnosed for heart failure, acute 
myocardial infarction, and pneumonia (these are common illnesses with the highest 
readmission rate according to CMS)?  
5. What is the discriminative ability of different groups of risk factors, such 
demographic variables, SES attributes, utilization variables, and laboratory measures, 
on predicting high-risk patients? Does this ability change for all-cause and specific-
cause readmission risk prediction? 
6. Statistically, how much change in readmission prediction we would expect in case of 
repeated measure and/or censored observations? How much variation do different 
levels of health care hierarchy such as patient level, provider level, and facility level 
account for?  
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We propose a feedback loop analytical framework that includes the key objectives for 
this research. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Proposed Framework 
Descriptive	  
Analytics	  
Predictive	  
Analytics	  	   Prescriptive	  Analytics	  	  
Identify	  cohort	  of	  interest	  with	  ICD-­‐9-­‐CM	  codes.	  Label	  readmission	  indices.	  
Aggregate	  patient-­‐level	  data	  with	  provider/facility	  tables.	  Do	  data	  pre-­‐processing	  and	  summarizing.	  
Recognize	  preventable	  readmissions	  by	  an	  analytical	  method	  and	  exclude	  others.	  
Develop	  population-­‐based	  models	  for	  readmission	  timing	  and	  occurrence.	  
Develop	  individual-­‐based	  models	  for	  readmission	  timing	  and	  occurrence.	  
Propose	  a	  hybrid	  approach	  with	  population-­‐based	  and	  individual-­‐based	  models.	  
Identify	  most	  common	  faults	  causing	  readmission:	  inadequate	  follow-­‐up,	  etc.	  
Optimally	  assign	  pre-­‐,	  bridging,	  and	  post-­‐discharge	  intervention	  programs	  to	  given	  set	  of	  patients.	  
Dynamically	  update	  patient	  risk	  prediction	  model	  and	  intervention	  allocation	  programming.	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In this research, we propose a risk prediction model based on hierarchical nonlinear  
mixed effect framework to extract significant prognostic factors associated with patient 
readmissions that mainly caused by patient non-compliance to the medication 
instructions. The novelty of our method is to directly incorporating patients’ history of 
readmissions, along with other patient characteristics, into the modeling framework thus 
enabling one to explain both patient and population based variations of readmission 
process at the same time. Moreover, we propose a predictive analytics framework that 
enables medical decision makers to characterize and (more accurately) predict avoidable 
readmissions, and to investigate the effects of different patient risk factors on the 
likelihood of rehospitalization. The goals of our study are three-fold: 1) to develop and 
internally validate an administrative algorithm for characterizing avoidable readmissions 
from all types of readmissions, 2) to address the difficulties around selection of an 
appropriate timeframe that defines readmissions for chronic conditions, and 3) to create 
and validate a simple and real-time readmission risk prediction model that can produce 
more desirable prediction accuracy than the literature. The proposed methods and tools 
are evaluated using a wide range of electronic health records from four Veteran Affairs 
(VA) hospitals in the State of Michigan.  
1.3. Dissertation Organization 
 
The dissertation is organized as follows. In chapter 2, first we propose an algorithm 
for identifying potentially avoidable readmissions and then we discuss about determining 
readmission time interval for chronic conditions. Next, we introduced phase-type 
distribution and phase-type Survival Forest for predicting the risk of readmission and 
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then, in the later part of the Chapter 2 we state some performance evaluation measures. 
In Chapter 3, we first describe the data source and the attributes, which is used for our 
research. In addition, the data preprocessing is presented completely. Next we determine 
the potentially avoidable readmissions rates for the given data from VA. With the help of 
proposed method in chapter 2, we predict the risk of readmission. Next, we do some 
descriptive analytics and compare different readmission risk prediction models with our 
proposed model. Conclusions and future studies are presented in Chapter 5 of the 
dissertation. 
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Chapter II Methods and Measures 
 
In this section, we first describe an algorithm built on administrative data to 
characterize avoidable readmissions from all outcomes. Then an analytical approach 
based on Coxian Phase type (PH) distributions is introduced to determine the optimal 
readmission time interval for chronic diseases and particularly COPD patients.  
2.1. Identifying potentially avoidable readmissions 
 
One of the main difficulties that makes the study of hospital readmission rather 
sophisticated is that no consensus yet exists on how to separate among so called “planned” 
readmissions (e.g., scheduled at or soon after the time of discharge) and those that might 
be prevented by implementing better transitional care programs. Different methods 
consider distinct outcomes and result in different readmission rates. Here we classify the 
existing approaches into two broad categories:  
• Methods designed to detect and exclude planned hospitalizations from the 
outcome of interest. Examples in this group include the well-known CMS method 
(Horwitz et al., 2015) and SQLape (Striving for Quality Level and Analyzing of 
Patient Expenses) (Halfon et al., 2002), which is a validated hospital comparison 
system practiced in Switzerland. 
• Methods intended to label avoidable readmissions from all index hospitalizations, 
such as 3M Health Information Division Potentially Preventable Readmission 
measure (Goldfield et al, 2008) . 
The CMS approach takes specific index stays and uses unplanned all-cause 
readmission rate as the primary outcome by removing all non-acute readmissions as well 
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as readmissions for maintenance chemotherapy. It employs AHRQ (Agency for 
Healthcare Research and Quality) Clinical Classification System (CCS) to identify 
planned procedures that contain an inpatient stay, along with the conditions that are acute 
or are complications of care and associated with the planned procedures. Also consistent 
with National Quality Forum (NQF) standards, the approach performs risk adjustment for 
case mix (patient comorbidity) and service mix (types of conditions/procedures cared for 
by the hospital) with the help of CMS Condition Category groupers. 
The 3M approach, on the other hand, considers all types of index hospitalization then 
decides on whether a readmission is avoidable with regard to clinical relationships 
between the reasons of admission and readmission. To this end, All Patient Refined 
Diagnosis Related Group (APR DRG) codes are first utilized to classify the patient 
cohorts; then a group of physicians evaluate the association between the initial admission 
and its following returns, and define preventable readmissions as those returns having a 
clinical relevance with the first hospitalization. Moreover, the approach makes use of 
APR DRG based Severity of Illness (SOI) measures to adjust for case mix risk factors.  
Both approaches are built (and validated) on administrative data, and they are mainly 
used for the purposes of (1) profiling hospitals with respect to their readmission rates and 
(2) adjusting Medicare or Medicaid payments to low-performing medical centers. 
However, according to a recent study in the VHA (Mull et al., 2013), they show only a 
moderate correlation in specifying the readmission rates, which is found related to the 
preventability element of the 3M method. 
In this study, since our goal is more to develop and validate a risk prediction model 
that can be used for clinical applications (rather than hospital profiling and payment 
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adjustment), we derive a hybrid approach adopting both the CMS and 3M rationales to 
choose from the patient outcomes. In a nutshell, we first apply the CMS method to 
exclude those planned procedures that are followed by a non-acute or a non-complication 
of care condition; then the 3M procedure is implemented on the remaining indices in 
order to extract potentially avoidable readmissions (PARs). However, we modify the 
exclusion criteria of both methods and implement VHA definitions of eligible discharge. 
To increase the overall precision of the proposal, we also got help from three reviewers to 
judge all cases identified, after completing each constituent algorithm. Moreover, instead 
of the APR DRG system, the newly-developed Diagnostic Cost Group Hierarchical 
Condition Category, version 21 (DCG/HCC v21) was utilized to assess the clinical 
relationship between each readmission and its initial admission(s) (Pope et al., 2004). We 
chose the DCG/HCC risk adjustment system because 1) it is a part of models that have 
been used and evolved over two decades of research; 2) it has special adjustments for 
elderly beneficiaries as well as patients with chronic conditions; and 3) it is recalibrated 
regularly according to recent modifications on diagnosis and expenditure data. 
The algorithm, which we call Potentially Avoidable Readmission (PAR), can then be 
stated as follows: 
Step 1 (general inclusion/exclusion) 
I. Identify HF, AMI, PN, and COPD cohorts based on principal (or 
secondary) discharge diagnoses, and eliminate all other conditions. Merge records 
of the same patient if he/she had multiple hospitalizations on the same day to the 
same medical unit. This applies to both medical and surgical patients. 
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II. Establish readmission time interval (henceforth T) and categorize each 
entry as either admission or readmission. Also, define eligible admissions as all 
admissions that are at risk of having a readmission.    
III. Exclude: 
a) From the admission set, cases whose discharge status is “death,” since 
they cannot have any readmission. These correspond to stand-alone admissions. 
b) From the admission set, cases whose discharge status are “transfer” to 
another acute care facility, except the four hospitals studied. The reason is that the 
hospital cannot affect a patient’s consequent care under such circumstances. If 
transferred among the four hospitals, however, the final discharging hospital is 
considered responsible for any readmissions. 
c) From the admission set, cases whose discharge status is “against medical 
advice.” Because in such cases, the planned treatment(s) could not be fulfilled and 
thus they do not represent a quality-of-care signal. 
d) From the readmission set, those entries that fall within 24 hours of their 
prior index discharge. This is consistent with the VHA operations policies. 
e) From the readmission set, cases in which any of the CMS planned 
procedures are conducted if not followed by an acute or a complication-of-care 
discharge condition category. Examples of such procedures include peripheral 
vascular bypass, heart valve, kidney transplant, mastectomy, colorectal resection, 
and maintenance chemotherapy. 
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f) From the readmission set, AMI patients hospitalized for a percutaneous 
coronary intervention (PCI) or coronary artery bypass graft (CABG), except those 
that are diagnosed for HF, AMI, unstable angina, arrhythmia, and cardiac arrest. 
g) From both admission and readmission sets, hospitalizations in long-term 
care, palliative care, nursing home, aftercare of convalescence, psychiatry, 
rehabilitation, and hospice wards; or for fitting of prostheses and adjustment 
devices. 
h) From both admission and readmission sets, stays for special conditions 
with high mortality risk, for which chances of post-discharge death is much higher 
than chances of being readmitted. These include, but are not limited to, patients 
with malignant neoplasm without specification of site; and medical patients with 
cancers of breast, skin, colon, upper digestive tract, lung, liver, pancreas, head, 
neck, brain, and fracture of neck of femur (hip). This is consistent with the CMS 
approach. 
i) From both admission and readmission sets, records that are related to 
major or metastatic malignancies, multiple trauma, burns, neonatal, obstetrical, 
Human Immunodeficiency Virus (HIV), and eye care.  The rationale is that these 
conditions usually require specialized follow-up cares and are often not avoidable. 
This is consistent with the 3M approach. 
j) From both admission and readmission sets, patients not enrolled in the VA 
and thus lacking sufficient historical data for the 12 months prior to the index 
admission. The logic is that the information is required to adjust for the case-mix 
and comorbidities. 
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k) From both admission and readmission sets, records with inconsistent 
and/or error components such as age and gender discrepancies, invalid HCC 
assignment, discharge date that preceded the admission date, disagreements 
between the patient’s VA status and its service-based attribute values, 
hospitalizations charged for less than $200 or greater than $4 million, and records 
with distances longer than 3000 miles. 
IV. Calculate eligible admissions as all records remaining in the admission set. 
Note that, situations described in a), b), and c), i.e., “death,” “transfer,” or 
“against-medical-advice” may happen to both admission and readmission entries. 
Step 2 (labeling PARs)    
V. Mark records from the readmission set that have a clinical relationship 
with their initial admissions as defined by one of the eight following categories: 
a) Readmissions for an ambulatory care-sensitive condition as specified by 
the AHRQ(Agency for Healthcare Research and Quality). 
b) Medical readmissions for repeated happening or extension of the reason 
for the initial (or a closely-related) condition. 
c) Medical readmissions for an acute decompensation of a chronic condition 
that relates back to the care given in the course or immediately after the initial 
admission (e.g., a return hospitalization for diabetes by an initially diagnosed AMI 
patient). 
d) Medical readmissions for acute medical complications acquired during or 
soon after the first admission (e.g., a readmission for addressing a urinary tract 
infection of a patient originally hospitalized for hernia repair). 
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e) Readmissions for a mental health or substance abuse condition that 
follows an admission for a non-mental health or non-substance abuse condition. 
f) Readmissions for mental health or substance abuse reason following a 
hospitalization for a mental health or substance abuse reason.    
g) Surgical readmissions to deal with repeated happenings or extensions of 
the condition causing the initial hospitalization (e.g., a readmission for 
appendectomy surgery of a patient who was initially admitted for abdominal pain 
and fever). 
h) Surgical readmissions to tackle a medical or surgical complication 
resulting during the initial admission or in the post-discharge course (e.g., a 
readmission for treating a post-operative wound resulting from an initial 
hospitalization for a bowel resection). 
Step 3 (clinical panel review) 
VI. All exclusions from step 1 and marked PARs in step 2 are reviewed by 
three physicians, and final decision about the outcomes was made by a majority of 
vote scheme. 
Step 4 (calculating PAR rate) 
VII. Define a PAR series as a sequence of one or more PARs that are all 
clinically associated with a similar initial admission. In this way, the succeeding 
PARs are always assessed for having a clinical relationship in reference to the very 
first admission (which starts the sequence), not with the intermediate PARs. As a 
result, the total time interval encompassing a PAR series can be larger than T. 
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VIII. Update the eligible admission set by reclassifying cases in the readmission 
set that are NOT found to be PARs (i.e., not having clinical relationship with their 
prior admissions) and at the same time, do not fall in “death”, “transfer”, or 
“against-medical-advice” categories.  
IX. Calculate PAR rate as #PAR Series
#  Eligible Admissions
. 
The DCG/HCC system is used throughout the algorithm to assess the clinical 
association between an initial admission and its PAR series. In other words, we first 
apply the CMS HCC model to assign HCC codes for all indices; then the reviewers 
examine the HCC codes of an initial admission and all of its related PARs to judge 
whether the readmission(s) could have been avoidable. If available, we also take into 
account other sources of information such as clinical visits between admission and 
readmission, and communication with the patient, patient’s family and primary care 
physician assigned, to help on the avoidability assessment of the PARs. 
The readmission time interval introduced in II is defined as 30 days for HF, AMI, and 
PN cohorts. For the COPD, we follow an analytical approach that is outlined in the next 
section. 
2.2. Determining readmission time interval for chronic conditions 
 
It is clear that, similar to the type of readmission (planned vs. avoidable), the length 
of time window between the dates of initial discharge and index readmission affects the 
ratio of avoidable readmissions (see sections VIII and IX in the PAR algorithm). The 
longer the interval is the more readmissions will be recognized and the more money the 
insurer could save under the bundled policy; however, the chances that a readmission has 
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a clinical relevance with its initial admission become diminished. Although the CMS and 
health policy makers adopt a 30-day time window for profiling hospitals and public 
reporting, other intervals from two weeks (Reed et al., 1991) to 180 days (Benbassat et 
al., 2010) are examined in different situations from certain types of surgery to a specific 
clinical condition. Researchers also raise the issue of improper interval selection in the 
literature (Hasan, 2011). In this study, to decide on the appropriate timeframe for COPD 
patients, first we examine the patterns of empirical readmission rates over days after 
discharge and recommend a graphical-based estimate; then we develop an analytical 
framework founded on Coxian phase-type distribution to determine the optimal cut off 
time defining the readmission. 
2.2.1. Graphical based approach  
 
The trend of COPD readmission rate over days following discharge is shown in 
Figure 4. Consider that the vertical axis displays percentage of patients not readmitted. 
As shown, the rate is high in the first weeks after discharge, then it levels off and 
becomes constant, before rising again near 60 days. The rate of (all-type) readmission is 
17.3% for the CMS-endorsed 30-day time window. However, inspecting the plot, we find 
that the slope of the readmission curve becomes stable around the 39th day, so we 
suggest that 39-day interval may be more appropriate choice for counting COPD 
readmissions. We believe this finding is also clinically justifiable because chronic 
conditions, as opposed to acute conditions, are getting worse over an extended amount of 
time so those readmissions that occur even after the 30th day may also be associated with 
the quality of the “inpatient” care and should thus be considered for transitional care 
intervention programs. 
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2.2.2. Phase-type distribution  
 
Phase-type (PH) distributions comprise a rich class of probability distributions that 
have been exploited extensively in various applications of stochastic modeling such as 
financial engineering, teletraffic modeling, drug kinetics, biostatistics, and survival 
analysis. 
 
                
     Figure 4 Percentage of COPD patients not readmitted 
 
The distribution is created by one or more inter-related Poisson processes on 
nonnegative real numbers, which can be represented as the time to reach an absorbing 
state in a finite-state continuous time homogeneous Markov chain. Despite its prevalence 
in other areas, the number of applications of PH distribution in healthcare literature is 
limited, with most publications focusing on modeling patients’ length of stay (Fackrell, 
2009). 
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Inspired by the observations from Figure 1, we assert that the rate of COPD 
readmission is not constant and changes over time. Further, using all-cause inpatient data 
from the same VA facilities, it was previously demonstrated that the (mean) hazard of 
readmission over time is influenced by a set of relevant patient factors including source 
of patient admission and treatment specialty (Shams et al., 2014). Therefore, it is desired 
to define the readmission timeframe in accordance with avoidability level and 
representativeness of quality care. We also recognize that the determination of the 
interval should not be based on the (instantaneous) risk or hazard of readmission, as the 
hazard (in the terminology of survival analysis) is a time-dependent conditional 
probability function that changes with both time and the patient’s case mix. On the other 
hand, since bias may be introduced when using the graphical inspection method, the 
approach taken should be able to objectively stratify the patients into clinically distinct 
groups according to avoidability strength of their readmission.  
Considering these characteristics, here we undertake a patient flow approach and 
develop a conceptual framework for the movements of patients after release from the 
hospital (see Figure 5). It is assumed that discharged patients travel between two major 
states (Short-Stay and Long-Stay) in their community before being returned to the 
hospital. In other words, patients begin their post-discharge period from the Short-Stay 
(SS) group consisting of m sequential transient phases; then they are either readmitted to 
the hospital at the rate of 𝜆!! or move to the Long-Stay (LS) group with rate  𝜆!. Patients 
entering in the LS group remain another r  (transient) phases in the community before 
going back to the hospital at the rate of  𝜆!". Here, consistent with the CMS and MedPAC 
logic, we ascertain that readmission from the SS group is a marker of poor quality of 
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inpatient care possibly because of premature discharge and poorly-designed process of 
inpatient care, whereas readmission from the LS group represents deficient quality of 
post-acute and outpatient follow-up care. Note that the rates are not identical within or 
between the two groups.  
The current framework results in a special case of order m r+  Coxian PH 
distribution, which is represented by an absorbing continuous-time Markov chain (CTMC) 
with m r+  transient states and one absorbing state (Hospital). Then the dynamics of the 
underlying finite-state stochastic process ( ){ }; 0X t t ≥  is governed by the transition 
intensity matrix { } ; ,h j h j Eα= ∈A  where { }1,2, ,E m r= +K  and  
( ) ( )
 
  
 
0
|
( ) lim ,
( ) ( ) .
th j
h h h j
h j
P X t t j X t h
t
t
t t
α
α α
Δ ↓
≠
+Δ = =⎡ ⎤⎣ ⎦=
Δ
= −∑
                                                                 (1) 
Hence, the random variable time to readmission T is equal to the time spent in the 
above CTMC until absorption in the Hospital state, which is also known as the sojourn 
time (Stroock, 2005). In this case, the probability density function f, the survival function 
S, and the k-th noncentral moment of T can be expressed by 
 
( ) exp( )( )f t t= −π Q Q1                                                                                                (2)                           
( ) exp( )S t t= π Q 1                                                                                                       (3)             
( k)( 1) ! ,  1,2,...kkm k k
−= − =Q 1                                                                                    (4) 
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where 𝜋 is the row vector of the initial probabilities over the transient states, Q is the 
(m+r) × (m+r) transient partition of the  intensity matrix, and 1 represents an (m+r) × 1 
column vector of 1’s. Here, exp (A) denotes the matrix exponential of a square matrix B 
(Golub, Van Loan, 2012). Based on the transition flow diagram shown, the Coxian PH 
distribution is represented by PH (𝜋, Q) where 𝜋 = (1, 0, K, 0) and Q ={𝑞!!}  can be 
simplified as: 
{ }
 
  
, 1  
,  
,  S S  ,  L S
1, 2, , -1                                  
1, 2, , -1, 1, m 2, , 1
;   
;  
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h h h
h h h
m m m m r m r
m r
m m m r
h
h
q
q
q q
λ
λ
λ λ λ
+
+ +
+
+ + + −
= =
= − =
= − + = −
KK K
                                                 (5) 
It is worth mentioning that the actual states of the Markov model are not observable; 
that is, we do not know the state (SS or LS) from which the patients absorb (readmit) to 
the hospital. In addition, the phases within each major state (SS and LS) do not carry any 
practical interpretations, but time spent in each phase follows an exponential distribution. 
Therefore, the PDF of time-to-readmission (2) can be viewed as a mixture of two 
generalized Erlang distributions (McLachlan, Peel, 2004) and then is reduced to  
SS LS( ) ( ) (1 ) ( )f t pf t p f t= + −                                                                                       (6) 
where SSf and LSf are the PDFs of the time-to-readmission for the Short-Stay and 
Long-Stay groups, with shape parameters m  and m r+  respectively, and p is the 
probability of a patient being in the Short-Stay group, which can be obtained by 
 
 
 S S
 S S  m
λ
λ λ+
. 
Following the methods discussed, we propose that the optimal cut-off point for the 
readmission time window is the point that separates the two components in (6), which, as 
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mentioned earlier, are corresponding to the readmission from inpatient and outpatient 
care spells one-to-one. Thus, the solution t∗  to 
SS LS( ) (1 ) ( )pf t p f t= −                                                                                                    (7) 
will give the optimal readmission timeframe. In order to solve (7), we need to 
estimate the 2( ) 1m r+ −  unknown parameters in (5) using approaches such as maximum 
likelihood (Asmussen, Nerman, Olsson 1996), moment matching (Johnson, 1993), or 
probabilistic clustering (Reinecke, 2012) that best fit with empirical data. Observing the 
time to readmission data 1 2( , , )Nt t t=t K , in the current paper, we use  the EM 
(Expectation-Maximization) algorithm to maximize the general log-likelihood function  
( )
1
log exp( )( )
N
i
t
=
−∑ π Q Q1  
with EMpht software (Asmussen S EMpht software, 2013). Further, by altering the number 
of phases, we select the models that best compromise model parsimony and goodness of 
fit based on both Akaike’s Information Criterion (AIC) (Akaike,1974) and Bayesian 
Information Criterion (BIC) (Schwarz 1978).  
2.3. Predicting potentially avoidable readmissions  
 
In the interest of reducing avoidable readmissions, it is necessary to note that in most 
cases, including all patients in the intervention programs is neither possible nor 
economically feasible. Thus to exploit the full potentials of such plans and raise their 
sustainability, it is beneficial to target patient subsets that are at higher risk of being 
readmitted. In this regard, predictive modeling approaches turned out to be promising not 
only in readmission risk prediction models, but also in other healthcare research areas 
such as hospital profiling based on patient health outcomes (Krumholz et al., 2006), 
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chronic disease management programs (Bayerstadler et al., 2013), and patient no-show 
problems (Alaeddini et al., 2011). Employing advanced statistical and/or machine-learning 
algorithms, such models typically try to predict the probability of an outcome given a set 
amount of health data including administrative, claim, or even medical laboratory data. 
Generally, risk of readmission needs to be assessed in two different episodes of the 
intervention programs, namely, pre-discharge and post-discharge. In the former, 
controlled variables that can be reasonably achieved before hospital discharge (for 
instance initial diagnosis) is fed into the model and the results are used to identify 
high-risk subgroups to receive the pre-discharge interventions like patient education and 
medication reconciliation. The latter, in contrast, make use of relatively all captured 
information such as LOS of the index hospitalization or principal diagnosis at discharge, 
and pinpoint high-risk cohorts to be assigned to post-discharge interventions like 
follow-up telephone calls and timely ambulatory visits. Also according to the type and 
timing of data gathered, predictive models can be applied for either profiling hospitals 
based on rate of readmission or predicting the chance of rehospitalization for a given 
patient.  
Suppose 𝐷 and 𝛿 denote the time to readmission and the readmission status (1= 
readmitted within 𝐷 days of the discharge, 0= Otherwise). Two modeling families with 
distinct objectives can be thought of for predicting patient readmission. The first group, 
which we call classification models, focus on readmission indicator 𝛿 and try to estimate 
it by first learning an algorithm based on inputted features and known class labels. These 
methods mostly use algorithmic models and treat the data mechanism as unknown (black 
box). Such models are usually prone to overfitting the training dataset in the case of small 
	  	  
32	  
sample sizes and/or repeated measurements. Nonetheless, they are computationally fast 
and easy to implement with minimal assumptions about the underlying mechanism that 
generates the data.  
The second group, which we name timing-based models, concentrate on 𝐷 and try to 
relate some of its probability functions to a given set of covariates in parametric 
(accelerated  failure  time models) or semi-parametric (proportional hazards models) 
fashion. As opposed to the first class, these methods are rather data models: the 
parametric timing-based methods have distributional assumptions for 𝐷 , and the 
semi-parametric ones have proportionality assumptions of the covariate effects. 
Nevertheless, they are capable of dealing with small (to medium) samples and also are 
able to update readily to take in new observations with minimum structural changes. In 
addition, models of this class have nice probabilistic interpretations of the outcome and 
they can incorporate correlations among the observations in the modeling process. 
Examples of the first group in readmission studies includes logistic regression (Shulan, 
Gao, Moore , 2013), random forest (Au et al., 2012), and support vector machines (Zhang et 
al., 2013), while the second group includes the Cox proportional hazard model (Hernandez, 
2010), and the lognormal frailty model. Although each model has its own merits and 
specific applicability, overall, it  is  found  that  most of the described techniques perform 
poorly in terms of discrimination power and predictive accuracy. 
Besides, according to current problems in readmission reduction programs, no 
consensus exists on the chosen set of patient (and system) factors that deemed related to 
the likelihood of readmission. This usually happens in studies comprising dissimilar 
health care settings (e.g., Medicare versus private health insurance) or diverse patient 
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populations (e.g., VA versus Non-VA). For instance, in a study of UK inpatients, the 
popular  LACE  measure (Length  of  stay,  Acuity  of  the  admission,  Charlson 
comorbidity score (Charlson et al., 1987), and Emergency  department  visits  within  six  
months) which works well in a number of UK populations, is found to be mediocre in 
predicting  30-day readmission rates. Therefore, we believe that in our study, a 
data-driven patient-centered approach should be developed to guide the decisions upon 
the readmission intervention programs. To this end, we do not impose a priori candidate 
variables to the modeling process nor do we limit our analysis to the previously-selected 
risk factors from other studies. 
Beyond these aspects, in order to fill the gaps in the literature and satisfy specific 
requirements of our modeling environment, we determined that a desired PM proposal 
should: 
• Be able to handle censored observations, which are common in time-to-event data. 
• Have the means to deal with repeated measure and recurrent event cases that may 
happen in longitudinal event history analysis. 
• Incorporate patients’ past history of readmission into the modeling framework.  
• Carry information about the timing of readmission. 
• Manage many relevant risk factors without having computational or inferential 
problems such as overspecification or multicolinearity. 
• Not be overly complex but should be computationally effective and easy to 
implement. 
• Be as stable as possible in a complex data environment. 
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• Discriminate very high from very low risk patients and be comparable (or superior) 
to the existing methods in terms of such performance indices as c-statistics. 
To fulfill the mentioned criteria, as well as to take advantages of both data models and 
algorithmic models, we propose our modeling methodology in the next section. 
2.3.1. Phase-type Survival Forest  
Decision trees are powerful and flexible non-parametric classifiers that use inductive 
inference for exploratory knowledge discovery. Due to their simple-to-comprehend and 
intuitive representation of information, decision trees have gained lots of attention in 
many disciplines such as computational biology, health informatics, medical imaging, 
and biomedical engineering (Breiman, 1993). A survival tree (Davis, Anderson ,1989) is a 
special kind of classification and regression tree (CART) for survival data that partitions 
the covariate space recursively to build groups (nodes in the tree) of subjects that are 
homogeneous with respect to the outcome of interest. This is typically done by 
maximizing a measure of node homogeneity like Wasserstein metric between the survival 
functions (Gordon, Olshen, 1985) or logrank statistics (Ciampi et al., 1986). A regular 
algorithm begins at the root node with all records and exhaustively searches all potential 
binary splits with the attributes, then picks the best one according to a splitting criterion 
such as a homogeneity measure. However, this process may lead to a large tree that 
usually overfits the data. To alleviate, a pruning mechanism is employed to find a subtree 
of appropriate size, or alternatively an ensemble approach (such as bagging or random 
forest) can be worked with which avoids the problem of selecting a single tree. Random 
Forest (Breiman, 2001) is a popular ensemble method that grows many (de-correlated) 
	  	  
35	  
classification trees by bootstrapping a training sample and then producing a label that is 
the mode of all votes from the individual trees.  
Following what was proposed, here we develop a special case of Breiman’s RF, a 
phase-type survival forest (PHSF), that 1) uses the PH likelihood (with censored 
observations) as its splitting criterion for each tree grown, and 2) deals with repeated 
measure and recurrent readmission situations by performing bootstrap sample at a subject 
(patient) level. 
• Slitting criterion 
We chose minimization of the weighted average information criterion (Wu, 
Sepulveda ,1998) as the splitting criterion to induce individual trees. WIC is a weighted 
average of BIC and bias-corrected AIC (Hurvich, Tsai 1989) which works better than (or at 
least as well as) other criteria in both small and large sample sizes. Recalling (2) and (3), 
the full log-likelihood function with censored observations becomes  
1
log( ( )) (1 ) log( ( )),
N
i i i i
i
L f t S tα α
=
= + −∑                                                                                  (8) 
where iα  is an indicator which equals 1, if it  is a complete time for the i-th 
hospitalization, and becomes zero if it  is a censored case (that is, no readmission occurs 
before the end of study). Notice that, censorship may occur for the three acute conditions 
(and the COPD) if no readmission is seen within 30 (or T) days of discharge. The WIC is 
calculated as 
( )
( )( ) ( )( ) ( )( ) ( )( )( )
( ) ( )( )( )( ) ( )( )
2log 1 log 1 2 1
WIC 2
2 log 1 1
d N N N d N N d
d L d
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+ − + − +
⎧ ⎫⎪ ⎪
⎨ ⎬
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                   (9) 
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in which 2( ) 1d m r= + − , is the PH number of degrees of freedom, and N  is the total 
number of sampled records. 
In such a manner, at each node of a tree, if covariate l  has G  values and breaks the 
node into partition set 1 2( , , ),Gl l K l then the total WIC for the split can be expressed by 
the sum of singular WICs of every sub-group partitioned by the covariate: 
full full
1
 WIC WIC .( ) ( )
g g
G
g
dd
=
=∑ l l                                                                                            (10) 
 
Therefore, the information gain is defined as the improvement made in the WIC after 
splitting the node:   
( )( ) ( )full fullWIC WIC ,R RIG d d= −l                                                                                      (11) 
 
where R  stands for the node before partition (i.e., the parent node). Beginning from the 
root node, at every single node, we apply one covariate at a time and record the gain for 
partitioning by that covariate. Then, we repeat this with other attributes and select a split 
that minimizes the WIC the most (or yields the largest gain) to recursively partition into 
child nodes. Also, if no positive gain can be obtained at a node by any possible split, the 
node becomes a terminal node. 
• Forest development 
As mentioned before, since patients (can) have multiple records in the dataset, 
repeated measures and recurrent events are likely. In this case, the bootstrapped samples 
are dependent and chances of having correlated observations in the in-bag training set are 
high. Consequently, trees grown may be correlated and overfitting is plausible. To 
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alleviate this problem, we developed the PHSF algorithm (Algorithm 1) that performs 
subject-specific bootstrapping rather than using traditional replicate-based bootstrap. 
According to the algorithm, a subject classification is calculated as the label with the 
maximum number of votes cast across all records for that subject among all trees. The 
PHSF is able to produce predictions for specific replicates of a subject, and it can also be 
reduced to the original random forest if no replicate per subject is available. Consistent 
with the rule-of-thumb, subject-level bootstrapping performed in the algorithm ensures 
that about 63% of the subjects (rather than replicates) are elected in-bag. In this way 
subjects with more replicates cannot dominate the training process. 
 
Algorithm 1. Phase-type Survival Forest 
I. For 1b =  to B : 
a) Take a bootstrap sample (i.e., a random sample chosen with replacement) of size S  at the 
subject level (patient) from the training data. Assuming jn  records per patient j , 
1 2 SN n n n= + + +L .  
b) Grow an unpruned tree bT  on each bootstrap by repeating the following steps, until no 
improvement is made in (11). 
i. Select vʹ′  variables at random from the whole v  variables. Normally vʹ′  should be 
much less than v , such as v  or even 1.    
ii. Following the splitting criterion introduced, pick the best variable among the vʹ′ , and 
split the node into two child nodes. 
II. Output the ensemble of trees { }1
B
bT .   
To make a prediction for a new patient x : 
Let ( )ˆ ( )b iC x  be the class prediction of the bth tree for replicate i  of the patient. Then 
{ }  1PHSF ( )ˆ ˆ( )  ( )
B
b iC x majority vote C x= .    
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      Considering that the PHSF generates proportions of votes for each class, similar to 
data models, we can have an (unbiased) estimate of the probability that a patient is 
readmitted. Further, like the original version of the random forest, the out-of-bag (OOB) 
data (which includes about one-third of all subjects) is used to get a running unbiased 
estimate of the classification error in both replicate and subject levels. Finally, like 
Breiman’s RF algorithm, we use the permutation-based measure to get a raw importance 
score for variable v  as: 
( )
 
, ,
1  .
B
v
c b c b
b
v
p p
I
B
=
−
=
∑
                                                                                                            (12) 
 
In the formula, ,c bp  is the proportion of correctly classified replicates out of total 
OOB replicates in a given tree, and ,
v
c bp  is the proportion of OOB replicates classified 
right after variable v  is randomly permuted across all OOB cases. 
2.4. Performance evaluation measures   
 
We compare the PHSF algorithm with four popular classification methods: Breiman’s 
Random Forest, Logistic Regression, Neural Network (NN), and Support Vector 
Machine (SVM). To evaluate the predictive accuracy of the approaches, we use 
sensitivity (also called true positive rate or recall), specificity, positive predictive value 
(or precision), negative predictive value, F-measure, Matthews correlation coefficient, 
and the area under the receiver operating characteristic curve (AUROC). Denoting True 
Positive (Negative) and False Positive (Negative) outcomes as TP (TN) and FP (FN), the 
predictive measures are computed as 
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sensitivity / ( )                        
specificity / ( )
PPV / ( )
NPV / ( )
F 2 / (2 )
MCC
( )( )( )( )
 
TN FP TN
TP TP FP
TN TN FN
TP TP FP FN
TP TN F
TP TP F
P FN
TP FP TP FN TN FP T
N
N FN
= +
= +
= +
= + +
× − ×
=
+ + + +
= +
                                                       (13) 
 
Sensitivity (specificity) determines the proportions of actual positives (negatives) that 
are correctly classified as such. Positive predictive value (PPV) measures the proportion 
of positive predictions that are true positive, while negative predictive value (NPV) 
indicates the proportions of negative test outcomes that are true negatives. The F-score 
can be interpreted as a harmonic mean of precision and recall, with a best value at 1 and a 
worst at zero. The Matthews correlation coefficient (MCC) is a correlation coefficient 
between observed and predicted binary tuples, which works well in class-imbalanced 
situations where the classes can be of very different sizes. Expectedly, it returns a real 
value in [–1,+1], in which +1 represents a perfect prediction, zero means no better than 
random prediction, and –1 shows total disagreement between prediction and observation. 
The ROC curve is a graphical tool that exemplifies the performance of a classifier by 
plotting, at various cut-off points for the predicted risk, the sensitivity vs. one minus the 
specificity. In other words, moving along the ROC from bottom-left to top-right trades 
off false positives for false negatives. The AUROC (or c-statistics) can then be defined as 
the proportion of times a given classifier correctly discriminates a random pair of patients 
with and without readmission. Stated differently, an AUROC of 0.77 indicates that a 
patient with readmission is credited with a higher prediction value than a patient without 
readmission 77% the time, for a random pair of patients with and without readmission. A 
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value of 0.5 for the AUROC shows that the model does not work better than a random 
pick; values between 0.7–0.8 suggest a modest separation ability; and values bigger than 
0.8 imply good discriminative power. A simple approach to calculating AUROC for 
binary classification is presented by ( Hand, Till, 2001) as  
0 ( 1) / 2ˆ ,S n nA
n n
+ −
+ −
− +
=                                                                                                             (14) 
 
where n+ and n−  are the number of positive and negative entries, respectively, and 
0 iS r=∑ , in which ir  is the rank of the i-th positive example in the ranked list. 
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Chapter III Result and Analyses 
 
In this section, we describe steps to implement the proposed methods with the VHA 
data. First, data preprocessing is presented in Section 4.1. Then we perform the PAR 
algorithm to recognize avoidable readmissions from all other types of outcome. After 
that, we fit the proposed Coxian PH distribution to COPD time-to-readmission data and 
find the optimal cut-off for the time interval. Finally, predictive modeling with the PHSF 
algorithm as well as details about model calibration and validation are presented. 
3.1. Data 
The dataset used in this retrospective cohort study is provided by the Veteran Health 
Administration (VHA), which is the largest single medical system in the United States, 
with 152 medical centers and nearly 1400 outpatient clinics. We analyze inpatient 
administrative records gathered from four medical facilities in the State of Michigan, 
namely, Ann Arbor, Battle Creek, Detroit, and Saginaw, to identify all hospitalizations 
for Heart Failure (HF), Acute Myocardial Infarction (AMI), Pneumonia (PN), and 
Chronic Obstructive Pulmonary Disease (COPD) from Fiscal Year 2011 to FY12. 
Cohorts are marked with ICD-9-CM (International Classification of Diseases, Ninth 
Revision, Clinical Modification) codes, similar to the coding utilized by the CMS for 
calculating hospital readmission rates.  
There were no major changes in the hospital bed supplies, and in the patient 
admission/discharge processes through that period of time. During a hospital stay, 
patients may move to different acute wards within the hospital and their episodes of care 
are carefully tracked with standard computerized means. We use additional data files for 
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patients with chronic conditions as well as patients exposed to environmental hazards 
such as Agent Orange, to effectively illustrate those impacts on the risk of readmission. 
The original set contains 7200 randomly selected records, which correspond to 2985 
distinct adult patients with principal (or secondary) discharge diagnoses of HF, AMI, PN, 
and COPD. General exclusions include: (1) Hospital admissions within 24 hours of index 
discharge, (2) Hospitalizations with a length of stay less than 24 hours (observation stays) 
or followed by a death, (3) Patients transferred to another acute care facility, (4) Patients 
discharged against medical advice. To count readmissions in the last month of FY12, the 
first month of FY13 is taken into account.  
In additions, we omit stays in long term care, nursing home, psychiatry, 
rehabilitation, and hospice wards. However, as we are interested in modeling the effect of 
patient’s related factor changes (over time) on the risk of readmission, unlike most 
studies in the literature (Joynt, Orav, Jha, 2011), we do not exclude recurrent 
(re)admissions of the same patient from the analyses. We also design both external and 
internal model validations by using stratified split sample and bootstrap resampling 
methods. 
3.1.1. Controlled variables     
We aggregate patient level data files with provider and station levels in order to 
obtain various types of risk factors for this study. To achieve a better picture of the data 
environment, we further arrange them into five groups: (1) Demographics: age at 
discharge, sex, race, and marital status; (2) Socioeconomic: means tested income, and 
insurance status (Medicare, Medicaid, private, none); (3) Utilization: length of stay of the 
index hospitalization (LOS), treating facility, source of admission (direct from home, 
outpatient clinic, transition from any of the four VA hospital, VA Nursing Home Care 
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Unit (NHCU), and VA domiciliary), primary care provider, enrollment priority, and 
average distance (between patient’s home zip code and the zip code of the facility he/she 
got admitted); (4) Service based: Agent Orange status, Prisoner Of War (POW) status, 
and radiation status; and (5) Comorbidity and severity: Diagnosis Related Group (DRG), 
Hierarchical Condition Category (HCC), and Care Assessment Need (CAN) score. Tthe 
variables were selected based on the relevant medical literature and confirmed by a group 
of Veteran Affairs (VA) health professionals.  
The enrollment priority is a priority level assigned according to the veteran’s severity 
of service-connected disabilities and the VA means test. The DRG is a validated 
reimbursement classification scheme exploited to identify the cost of services that a 
hospital renders. In its basic version, the groups are organized with respect to their 
similarities in patient diagnosis, age, sex, and the presence of complications or 
comorbidities; then a measure of cost is attached to each group (Fetter et al., 1980).  
HCCs have been used ad hoc, mainly for case-mix and risk adjustment in healthcare 
utilization and payment systems. Each HCC group forms a set of clinically and 
cost-similar conditions reflecting hierarchies among related diseases as defined by the 
ICD-9-CM codes (Pope, 2004). We create dummy variables for both the DRG and HCC 
variables in the regression studies; that is, if a patient is a member of the category, he or 
she is given a 1 on this variable; otherwise the score remains zero. The CAN score is a 
general illness severity score that reflects the likelihood of admission or death within a 
specified time period, and it works somewhat similar to diagnostic cost group (DxCG) 
risk score (Sales, 2013). The score is commonly expressed as a percentile ranging from 0 
(lowest risk) to 99 (highest risk) and it shows how a VA patient is compared with others 
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pertaining to the chances of hospitalization or death. It is interesting to note that all 
predictor variables except LOS are real time and would be available before patient 
discharge, so they can be employed in planning for pre-discharge (transitional care) 
intervention programs.    
3.1.2. Study outcomes     
The main outcome is rate of avoidable readmission after discharge. Unlike the large 
literature that studies only the occurrence of readmission by logistic (or probit) regression 
methods (Berry et al., 2013; Pracht, Bass 2011), our current approach is a hybrid of both 
occurrence and timing of readmission, which enables us to directly incorporate the effect 
of partially known inforamtion (censored observations) into the risk of readmission. For 
hospitalizations after HF, AMI, and PN, we follow the CMS approach and define the 
readmission time interval as 30 days; if no consecutive admission is occurred within 30 
days after the most recent admission, the outcome is flagged as censored. For COPD 
patients, however, we do not adopt the 30-day cutoff, and instead develop an approach to 
optimally determine the interval that best stratifies the quickly-readmitted and 
slowly-readmitted patient groups. We further modify the approach introduced by 
(Goldfield et al., 2008)t o distinguish between avoidable and unpreventable outcomes.  
The most common causes of readmission for the four cohorts as well as their changes 
over time are also investigated as secondary health outcomes. 
3.1.3. Data preprocessing   
 
Since real world data generally contain missing values, noise (e.g., errors and 
outliers), and inconsistent records, data preprocessing is essential for ensuring valid 
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analytics. In this regard, added to what is given in the PAR algorithm (section II, part k), 
we perform the following tasks: 
a) Create attributes for time-to-readmission, readmission status, LOS, and 
sequence of (repeated) readmissions using admission and discharge dates. 
b) In predictive model building, we use the default replacement method of 
Breiman’s algorithm for missing values. For univariate analysis, however, missing 
values are imputed with the hot-deck method (Ford ,1983). 
c) Identify and remove extreme records (outliers) with Local Outlier Factor 
(LOF) technique (Breunig et al., 2000). 
d) Correct error records and flawed data combinations (e.g., POW: Yes, 
Veteran: No).  
e) Discretize attributes like distance into three levels (near: below 25 miles, 
middle: between 25 and 50 miles, far: above 50 miles) by k-means clustering.  
Following these steps, the number of records is reduced to 6975 with 2813 distinct 
patients. 
3.1.4. Statistics 
 
Our main outcome was avoidable readmission measured by the PAR metric in the 
first 30 days of hospital discharge. We first examine the presence of any difference in the 
baseline characteristics between the cohorts using univariate logistic regression. Since the 
same patient could have several avoidable readmissions during the study, we used 
generalized estimation equation to adjust for serial correlations among readmissions of 
the same patient. 
Then, using the entire set of patient risk factors, we performed a random forest 
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analysis. Random forest (Breiman, 2001a) is a popular nonparametric method that grows 
many classification trees by bootstrap resampling technique to estimate the aggregated 
probability of an outcome. Although they were recently adopted in estimating propensity 
scores (HSR paper, 2013), few researches have studied the use of random forest to 
predict the risk of readmission (AHJ paper, 2012). Each tree provides a classification 
based on a set of randomly chosen predictor variables that are used to split the data at 
each node.  
With this set of trees, the ability of each predictor to separate the patient who had or 
did not have the outcome is assessed and weighted with respect to the overall quality of 
the tree. Then importance of each covariate in all tress is summarized by a Gini index, 
which tells how much accuracy of the prediction is lost if the variable is not included. 
Such methods proved to increase the accuracy of prediction compared to classical 
statistical methods such as logistic and probit regression (Breiman, 2001b). 
Since we are interested in studying the effect of having previous readmissions on the 
likelihood of outcome, we modify the random forest algorithm in a way that it can handle 
the correlation among repeated measures and recurrent events of the same subject. The 
basic idea is to have the forest take a bootstrap sample at the patient level rather than at 
the replicate level, i.e. doing subject-specific bootstrap instead of traditional 
replicate-based bootstrap. This way, when a particular patient is chosen at random, all of 
its replicates (repeated measures) that had the outcome (recurrent events) or did not have 
the outcome are attached to it. Hence, trees grown are not correlated and overfitting is 
avoided. For instance, patients with more repeated measures cannot dominate the 
learning process in the training data (HCMS paper, 2014). 
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We started by including all risk factors into the random forest to estimate the 
predicted probability of avoidable readmission. We additionally created a new variable 
called ‘sequence’ for determining how many times a given patient was readmitted in the 
study. Except age, length of stay, CAN score, Charlson comorbidity index, and sequence, 
all other covariates are entered as dummy variables. We set the number of trees to grow 
and the number of variables to randomly split at each node as 5,000 and 5, respectively.    
The latter number is the suggested default and equals to the square root of the total 
number of variables in the algorithm. We also investigated what the optimal cutpoint for 
continuous variables should be that most discriminate high vs. low risk patients using 
operating characteristic curves.  
We then performed two sensitivity analyses: (1) sensitivity of random forest error 
rates to our selected parameters by letting the number of trees to change between 2,000 to 
5,000 and the number of randomly chosen variables to vary between three to seven, and 
(2) sensitivity of error rates to class weights by setting different weights for the two 
cohorts that had or did not have the outcome. Finally, we conducted internal validation 
with same population underlying the sample, as well as external validation with a new 
patient sample. We used R platform for all analyses and statistical computing (RCD, 
2005). 
3.2. Potentially avoidable readmissions rates   
 
Using 30-day (and T-day; see Section 4.3) readmission timeframes for the three acute 
conditions (and COPD), we begin by classifying all records to admissions and 
readmissions. Removing instances from the admission and readmission sets that meet one 
or more exclusion criteria (see section III of the PAR algorithm), we initially identify 
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total of 5,449 eligible admissions and 968 readmissions. Of the 968 readmissions, 173 
cases were found not clinically related to their prior admissions (see PAR algorithm, 
section V), from which 27 cases are fitted in either “death,” “transfer,” or “against-
medical-advice” groups and thus be dropped. The remaining 146 readmissions were then 
reclassified as eligible admissions, resulting in 5,595 eligible admissions. Hence, we end 
up having 795 PARs, from which 596 examples belong to a PAR series with only one 
PAR, and 78 match to a PAR series with two or more PARs. Consequently, the total 
number of unique PAR series becomes 674, and the PAR rate (see section IX of the PAR 
algorithm) is found to be 12.05 percent. Following the same appraoch, rates of PAR for 
HF, AMI, PN, and COPD are 13.26, 12.47, 11.16, and 11.33 percent. 
The facility-adjusted PAR rates vary from 12.37% to 13.69% for HF; 11.83%–13.16% 
for AMI; 10.74%–11.93% for PN, and 10.68%–12.13% for COPD.  From all HF 
avoidable readmissions, 86.3% are readmitted once, 11.4% are readmitted twice and 2.3% 
are readmitted three or more times. These rates are (81.7%; 14.6%; 3.7%), (88.4%; 
10.9%; 0.7%), and (83.2%; 14.7%; 2.1%) for AMI, PN, and COPD respectively. 
The pattern of PAR rates for the three acute conditions and the COPD during 
cumulative periods after discharge (days 0–7, 0–15, 0–21, and 0–30) are outlined in 
Table 1. As shown, of all 30-day avoidable readmissions, nearly 58% of the HF, 55% of 
the AMI, and 60% of the PN cohorts occurred within 15 days after hospital discharge. In 
other words, the majority of acute (avoidable) readmissions happens relatively soon after 
discharge, and they remain common even after two weeks of discharge. However, only 
around 58% of all COPD (avoidable) readmissions take place until the third week after 
discharge, and nearly 22% is left beyond the 30 day interval, which supports our 
	  	  
49	  
argument about the inappropriateness of the 30-day timeframe for the chronic disease. 
This finding can be of great value for health professionals when they plan to allocate 
inpatient and early outpatient intervention programs to both acute and chronic conditions. 
The mean (standard deviation) patient age of the readmitted cohort is 78.6 years (3.5 
years) for HF, 80.3 years (4.1 years) for AMI, 79.3 years (2.9 years) for PN, and 76.2 
years (3.1 years) for COPD. Frequent comorbid conditions among readmissions are 
coronary artery disease (CAD), atrial fibrillation, and diabetes for the HF cohort; anemia, 
congestive heart failure, and vascular disease with complications for the AMI cohort; 
chronic obstructive pulmonary disease, congestive heart failure, and cardiorespiratory 
failure and shock for the PN cohort; and chronic bronchitis, pneumonia, and diabetes 
mellitus for the COPD cohort. 
 
                       Table 1 Distribution of avoidable readmissions over time 
 
 
 
 
 
 
The most common diagnoses of 30-day (or T-day; see Section 4.3) readmission after 
HF, AMI, PN, and COPD hospitalizations are displayed in Table 2. It appears that after 
admission for HF and AMI, readmissions happen mostly for heart failure (39.6% and 
28.3% of readmissions, respectively), but following hospitalizations for PN and COPD, 
patients get readmitted because of COPD (21.4% and 32.5%, in turn). Also, the top five 
Cohort 
Days following discharge 
0–7 0–15 0–21 0–30 
Heart Failure 28.6% 57.9% 81.7% 100% 
Acute Myocardial Infarction 33.4% 54.6% 86.4% 100% 
Pneumonia 31.1% 60.1% 83.3% 100% 
COPD 21.1% 42.6% 58.5% 78.3% 
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readmission diagnoses contribute to 63.2% of all readmissions after HF, 59.4% of all 
readmissions after AMI, 55.6% of all readmissions after PN, and 65.1% of all 
readmissions after COPD.  
Further, we realized that the most frequent reasons for avoidable readmissions in all 
conditions are related to “recurrence or extension of the reason (Section V, part b)” and 
“medical complications (Section V, part d)”, with an average of 54.7% and 23.2% 
through all the hospitals. As expected, in none of the acute and chronic conditions is the 
proportion of non-clinically related readmissions over 15.4 percent.  
 
Table 2 Top readmission diagnoses for patients hospitalized with HF, AMI, PN, and  
COPD 
Rank HF cohort AMI cohort PN cohort COPD cohort 
Diagnosis Percent 
of PAR 
Diagnosis Percent 
of PAR 
Diagnosis Percent 
of PAR 
Diagnosis Percen
t of 
PAR 
1 Heart failure 39.6% Heart failure 28.3% COPD 21.4% COPD 32.5% 
2 Renal failure 9.3% Coronary 
artery 
disease 
13.7% Pneumonia 15.3% Bronchitis 16.3% 
3 Arrhythmias 6.7% Pneumonia 8.6% Heart failure 10.6% Cardio-
Respiratory 
Failure and 
Shock 
7.6% 
4 Cardio-respir
atory failure 
and shock 
4.1% Septicemia/
Shock 
5.5% Cardio-respi
ratory 
failure and 
shock 
4.4% Pneumonia 5.3% 
5 Pneumonia 3.5% Renal failure 3.3% Renal failure 3.9% Hypertension 3.4% 
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Next, we compared percentages of readmissions calculated by our method (PAR) to 
those of the 3M method for the three acute conditions in the four hospitals (Figure 6). In 
our method, consistent with the literature (Medicare Payment Advisory Commission, 
2007), we observe that a greater proportion of all readmissions can be avoided in the first 
two weeks after discharge, but the contribution declines as time passes. Compared to the 
3M approach, our method considers (slightly) fewer rehospitalizations as being avoidable 
and produces lower rates of readmission throughout all periods after discharge. A 
probable reason for this may be related to the CMS- and VHA-specific exclusions of our 
method, which is not found in the 3M approach. Besides, almost the same trend (not 
shown here) is seen for the COPD readmissions but over an extended time interval 
following discharge. 
 
 
 
 
 
 
 
 
 
 
Figure 6 Percent of readmission over 
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3.3. Optimal COPD readmission timeframe   
 
In this section, we fit the proposed Coxian PH distribution to COPD 
time-to-readmission data in order to find the optimal cut-off point that defines avoidable 
readmissions. Using empirical data, we first examine the percentile distribution of times 
in Table 3. 
Table 3 Percentile distribution of the COPD time to readmission 	   	  
 
 
As shown, the median time-to-(avoidable) readmission is about 36 days and the 
distribution is (highly) right skewed, with more than half of patients readmitted after the 
30th day from discharge. This implies that, unlike acute conditions, poor quality of 
inpatient care for chronic conditions may reveal itself after 30 days from discharge. So 
setting the 30-day as a fixed timeframe for both acute and chronic conditions may not be 
appropriate. 
We then applied the EMpht software to estimate the phase-type generator Q  in (5) 
using COPD time-to-readmission data from FY 11–12. In brief, the program starts with 
an initial guess (0)Q  (for the non-zero elements in (5)) and proceeds with a number of 
iterations of the EM algorithm to increase the log-likelihood function 
( )
1
log exp( )( )
N
i
t
=
−∑ π Q Q1 .  
Fixing the maximum number of iterations at 5000 runs and Runge-Kutta step length 
at 
 
0.1
max i iQ
 (in which 
 
max i iQ is the largest absolute value of the diagonal element of 
Percentile 0 10 25 50 75 90 100 
Day 1 7 19 36 88 174 283 
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the last estimate of Q ), we configure different Coxian PH structures by modifying the 
order of the sub-class Markov processes (i.e., parameters m and r ). This way, we start 
with 1m = , examine various levels of r from 1 to 10, and pick the best in terms of AIC 
and BIC; then we repeat this for 2m =  until 10m = . We stop the search if the 
log-likelihood does not improve in any intermediate level. Also due to non-identifiability 
of the parametrization of the phase-type distribution (O’Cinneide CA, 1990), we do several 
fits starting with various initial values produced in previous runs. The results of best fits 
at each level of m  are then summarized in Table 4. 
It is apparent that there is no improvement in the fits after the fourth phase of the 
Short-Stay group (i.e., m=4). Hence an order 6 of the Coxian PH distribution with 4 and 6 
phases for the Short-Stay and Long-Stay groups respectively is considered to most 
suitably represent the time-to-readmission process of the COPD patients in the dataset. 
Note that we do not show fits after (m=5) as they provide no further enhancements. 
 
Table 4 Results of various Coxian PH fits 
Fit r AIC BIC 
m=1 3 35443.4 35443.02 
m=2 2 35181.3 35180.90 
m=3 1 34077.7 34077.32 
m=4 2 33816.5 33818.28 
m=5 2 33844.2 33851.54 
 
The estimates of the intensity rates in (5) along with their standard errors are 
calculated in Table 5. Given the small amounts of error, we see that the parameters are 
well estimated with EMpht. Also note that 1 λ ,  2λ , and  3λ  belong to the Short-Stay 
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group, while  4λ  and  5λ  are related to the Long-Stay group. According to the table, the 
probability of a patient being in the Short-Stay group is calculated as 
1.26 0.4437
1.26 1.58
p = =
+
, 
which means that the COPD patients spend about 44.37% of their time in the 
Short-Stay group in the community before returning to the hospital. 
Then, in order to solve (7) and obtain the optimal COPD readmission timeframe, we 
need to derive the PDFs SSf  and LSf . This can be done based on a convolution of a set 
of independent exponential variables ( iX ) as follows (Ross, 2009): 
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  0iλ is zero for all phases except m and m+r, that is, 
 
	  	  
55	  
{ }
  
 
   0  S S  0  L S
 0 1, 2, , -1, 1, m 2, , 1
 ,                                
0;  
m
i
m r
m m m ri
λ λ λ λ
λ
+
+ + + −
= =
= = K K                                        (16) 
Finally, by substituting (15) in (7) with 0.4437p = , we compute t∗  (or T in the PAR 
algorithm) as 42 days, which is pretty close to, but more accurate than what we observe 
in Figure 1. Thus, for the COPD cohort we should utilize a 42-day timeframe to count the 
correct number of avoidable readmissions in our study. 
3.4. Predicting the risk of avoidable readmissions 
 
In this section, we first perform some descriptive analytics on the patient risk factors 
for the two cohorts within each condition. Afterwards, steps for predictive modeling 
along with details about model validation and calibration are described. We then end by 
doing performance evaluation and comparison studies. 
Table 5 Estimated intensity rates for the COPD Coxian PH model 
Parameter Estimate Standard 
Error 
1 λ  0.04 0.008 
 2λ  3.62 0.126 
 3λ  5.17 0.233 
 4λ  1.58 0.075 
 5λ  0.96 0.039 
  SSλ  1.26 0.097 
  LSλ  0.83 0.004 
 
3.4.1   Descriptive Analytics  
 
Baseline patient characteristics in PAR and No-readmission cohorts are displayed in 
Table 6 (for Heart Failure and Acute Myocardial Infarction) and Table 7 (for Pneumonia 
and COPD). The presence of any significant difference between the cohorts was also 
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tested using univariate logistic regression and the results are shown in terms of P-Values 
[missing values are imputed by the hot-deck method]. Since the same patient could have 
several avoidable readmissions during the study period, we used generalized estimation 
equation to adjust for serial correlations among readmissions of the same patient.  
During the study, a total of 5,595 eligible admissions were made in the four VA 
hospitals, out of which about 14. 21%  were followed by an unnecessary rehospitalization. 
Note that this rate is different from what is reported in Section 4.2 (which is 12.05%) 
because here we count each readmission separately rather than as members of a PAR 
series. In all conditions, the populations are generally male (>86%), married (>51%), 
older (>67 years), and live within 25 miles of a VA facility (>60%).  
More than 21% in all conditions do not have private insurance or insurance through 
Medicare or Medicaid programs. More than half of patients in all conditions are admitted 
directly from their home and more than 50% have one to four past-year hospitalizations. 
On average, the care assessment score is higher in respiratory diseases (near 69) 
compared to circulatory conditions (about 66). Almost 18% of the patients are also 
diagnosed with more than ten HCCs (not shown in the tables).  
Note that in the attribute “source of admission,” class ‘transfer’ is related to those 
patients who are transferred only among the four VA hospitals, and ‘Other’ is related to 
some other admission sources such as observation/examination, non-VA hospitals not 
under VA auspices, community nursing homes under (or not under) VA auspices, 
non-veteran hospitals, etc. Further, priority groups 1, 2, and 3 are generally assigned to 
veterans with service-connected disabilities of > 50%, [30%, 50%), and [20%, 30%), 
respectively. Other groups are as follows: 4, catastrophically disabled veterans; 5, low 
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income or Medicaid; 6, Agent Orange or Gulf War veterans; 7, non-service connected 
with income being below HUD; and 8, non-service connected with income being above 
HUD. For each condition, patient comorbidities are identified with the help of 
Comorbidity Software (Kaboli et al., 2012), using ICD-9-CM and DRG codes from the 
index hospitalization and any admission in the 12 months prior. 
It is observed that patients who are subsequently readmitted are elderly and usually 
have a greater number of comorbidities. Male patients have on average a greater chance 
to be readmitted in HF and COPD cohorts rather than females, but this cannot be 
generalized since the VA sample here contains only about 8% female patients.  The 
analysis shows that length of stay is not generally associated with odds of avoidable 
readmission, when patient and facility characteristics are not controlled for.  
However, after adjusting for the case-mix and service-mix (not shown here), the 
relation tends to be negative (about 7.3% increase for each in-hospital day lower than 
expected), which implies that shorter individual LOS is generally connected with higher 
risk of readmission. Therefore, consistent with (Kaboli et al., 2012), we observe that 
significant reduction in LOS, without simultaneously improving inpatient care, is more 
likely to result in premature discharge and rehospitalization. Further, enrollment priority 
turns out to be highly linked with odds of readmission in all conditions, especially when 
it comes to catastrophically disabled veterans (increases of .2% in AMI to 10.9% in HF). 
Furthermore, the odds of avoidable readmissions are significantly higher in patients 
exposed to ionizing radiation and Agent Orange in all conditions. Among the comorbid 
conditions, having diabetes and cancer increases the chance of readmission, as does 
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having mental disorders and substance abuse (with harsher effect in circulatory 
conditions). 
3.4.2   Predictive modeling with PHSF 
 
Following Algorithm 1, we used the entire set of patient risk factors to develop a 
readmission prediction model. Additionally, we create two more covariates, namely, 
“sequence” and “Charlson comorbidity index” and entered them into the analysis. For 
non-categorical variables in the candidate set (i.e., age, LOS, CAN score, sequence, and 
Charlson index), we evaluated different cut-off points to split the dataset into binary 
partitions and explore the optimal cutpoint that most discriminates high vs. low risk using 
operating characteristic curves (with whole dataset). We then used this ROC-generated 
cutpoint for further analyses. Also for categorical features with more than two classes 
(like race), following (Friedman, Hastie, Tibshirani, 2009) we optimally select a series of 
binary splits (instead of multiway splits) that produce the best discrimination results.  
 We begin with the baseline model that uses all sampled data points (5,595 records) in 
the subject-specific bootstrapped PHSF and we let the forest internally perform 
cross-validation using OOB samples during each run. The number of trees and the 
number of variables to try at each split are set to 6,000 and 5, respectively. Also we set 
the cutpoints with respect to minimizing the WIC criterion (see Section 3.1.1) as follows: 
Age, 68 (years); LOS, 5 (days); CAN score, 66; sequence, 3; and Charlson index, 4.5. 
Results of variable importance are summarized in Table 8 (Sig. stands for significance 
level).  
As illustrated, almost all statistically significant variables (Sig. <.05) refer to overall 
health and agedness factors, which may reflect a generalized vulnerability to disease 
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among recently discharged patients—inpatients regularly lose their strength and develop 
new difficulties in doing their day-to-day activities (Gill et al., 2010). Interestingly, 
‘sequence’ turns out to be (positively) related to readmission risk, which highlights the 
fact that the chance of unnecessary returns to hospital is greater in patients with prior 
history of readmission. 
In the baseline model, the c-statistics is .793; sample-level OOB error rates are 3.16%, 
2.35%, and 8.05% for overall, No-readmission class, and PAR class, respectively; and 
there are large interactions [based on Breiman’s variable interaction model [46]] between 
Agent Orange and Radiation, between Priority and LOS, and between Priority and 
Insurance, to name a few. 
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Table 6 Baseline characteristics (mean (SD) for continuous variables; n(%) for 
categorical variables) 
 Heart Failure 
(n=1674) 
 Acute Myocardial Infarction 
(n=1417) 
Characteristic No Readmission 
(n=1447) 
PAR 
(n=227) 
P-Value  No Readmission 
(n=1211) 
PAR 
(n=206) 
P-Value 
Age (years) 68.6 (5.2) 71.3 (3.2) <.01  69.3 (5.6) 73.3 (3.7) <.01 
Sex, Male 1406 (97.2) 215 (96.9) .04  1097 (90.6) 192 (93.2) .07 
Race 
Black 
White 
Other 
 
986 (68.1) 
432 (29.8) 
  29 (2.1) 
 
193 (85.0) 
  29 (12.8) 
  5 (2.2) 
 
 
<.01 
 
  
769 (63.5) 
405 (29.8) 
  37 (3.1) 
 
169 (82.0) 
  29 (14.1) 
    8 (3.9) 
 
 
<.01 
 
Marital status 
Current spouse 
Never married 
Previously married 
 
839 (57.9) 
307 (21.2) 
301 (20.9) 
 
137 (58.3) 
  52 (21.4) 
  38 (20.3) 
 
 
.35 
 
  
631 (52.1) 
320 (26.4) 
260 (21.5) 
 
112 (54.4) 
  58 (26.7) 
  36 (18.9) 
 
 
.42 
 
Primary insurance 
Medicare 
Medicaid 
Private 
Not insured  
 
732 (50.6) 
249 (17.2) 
107 (7.4) 
359 (24.8) 
 
126 (55.5) 
  27 (11.9) 
  25 (11.0) 
  49 (21.6) 
 
 
.03 
 
  
624 (51.5) 
226 (18.7) 
103 (8.5) 
258 (21.3) 
 
  97 (47.1) 
  32 (15.5) 
  28 (13.6) 
  49 (23.8) 
 
 
.07 
 
Length of stay (days) 5.2 (6.1) 6.2 (4.4) .07  5.8 (5.8) 5.1 (6.8) .11 
Source of admission 
Direct from home 
Outpatient clinic 
Transfer 
VA NHCU 
VA Domiciliary 
Other 
 
797 (55.1) 
392 (27.1) 
  17 (1.2) 
  62 (4.3) 
  13 (0.9) 
166 (11.5) 
 
129 (56.8) 
  63 (27.8) 
    3 (1.3) 
  12 (5.3) 
    4 (1.8) 
  16 (7.0) 
 
 
 
 
.31 
  
623 (51.4) 
392 (32.4) 
  23 (1.9) 
  62 (5.1) 
  13 (1.1) 
  98 (8.1) 
 
107 (51.9) 
  67 (32.5) 
    4 (1.9) 
  10 (4.9) 
    5 (2.4) 
  13 (6.3) 
 
 
 
 
.26 
Enrollment priority 
1 
2 
3 
4 
5 
6 
7 
8 
 
126 (8.7) 
167 (11.5) 
293 (20.2) 
173 (12.0) 
316 (21.8) 
115 (7.9) 
103 (7.1) 
154 (10.6) 
 
17 (7.5) 
  9 (4.0) 
38 (16.7) 
52 (22.9) 
66 (29.1) 
15 (6.6) 
19 (8.4) 
11 (4.8) 
 
 
 
 
 
<.001 
 
 
 
  
104 (8.6) 
136 (11.2) 
239 (19.7) 
133 (11.0) 
331 (27.3) 
172 (14.2) 
  26 (2.1) 
  70 (5.8) 
 
19 (9.2) 
13 (6.3) 
41 (19.9) 
23 (11.2) 
56 (27.2) 
12 (5.8) 
15 (7.3) 
27 (13.1) 
 
 
 
 
 
<.001 
 
 
 
Distance to hospital 
Near (<25m) 
Middle ([25, 50]m) 
Far (>50m) 
 
856 (59.2) 
549 (37.9) 
  42 (2.9) 
 
155 (68.3) 
  69 (30.4) 
    3 (1.3) 
 
 
.02 
 
  
781 (64.5) 
406 (33.5) 
  24 (2.0) 
 
151 (73.3) 
  53 (25.7) 
    2 (1.0) 
 
 
.03 
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Table 6 continued 
 
 
 
 
 
 
 
 
 Heart Failure 
(n=1674) 
 Acute Myocardial Infarction 
(n=1417) 
Characteristic No Readmission 
(n=1447) 
PAR 
(n=227) 
P-Value  No Readmission 
(n=1211) 
PAR 
(n=206) 
P-Value 
Radiation, Yes 11 (0.8) 5 (2.2) .03  9 (0.7) 6 (2.9) .02 
Agent Orange, Yes 63 (4.4) 16 (7.0) .02  42 (3.5) 13 (6.3) .03 
CAN score 67.4 (4.1) 71.7 (2.9) <.01  64.5 (4.6) 68.6 (3.7) .02 
No. of past year 
hospitalization 
0 
1-4 
>4 
 
 
663 (45.8) 
713 (49.3) 
  71 (4.9) 
 
 
  71 (31.3) 
122 (53.7) 
  34 (15.0) 
 
 
 
<.001 
 
  
 
503 (41.5) 
616 (50.9) 
  92 (7.6) 
 
 
  52 (25.2) 
124 (60.2) 
  30 (14.6) 
 
 
 
<.001 
 
Comorbidity 
CAD 
Heart failure 
Vascular disease w/c 
Cardiorespiratory  
Pneumonia 
Atrial fibrillation 
Anemia 
Diabetes 
COPD 
Chronic bronchitis 
Malignant neoplasm 
Mental disorder 
Substance abuse 
 
486 (33.6) 
— 
202 (14.0) 
153 (10.6) 
  97 (6.7) 
403 (27.9) 
225 (15.5) 
351 (24.3) 
242 (16.7) 
  83 (5.7) 
  71 (4.9) 
160 (11.1) 
118 (8.2) 
 
94 (41.4) 
— 
45 (19.8) 
37 (16.3) 
19 (8.4) 
77 (33.9) 
47 (20.7) 
71 (31.3) 
49 (21.6) 
12 (5.3) 
19 (8.4) 
37 (16.3) 
31 (13.7) 
 
.04 
— 
.02 
.01 
.32 
.05 
.05 
.02 
.05 
.66 
.03 
.01 
<.01 
  
  81 (6.7) 
346 (28.6) 
306 (25.3) 
134 (11.1) 
  51 (4.2) 
291 (24.0) 
378 (31.2) 
159 (13.1) 
  63 (5.2) 
  17 (1.4) 
  25 (2.1) 
102 (8.4) 
112 (9.2) 
 
16 (7.8)  
73 (35.4) 
67 (32.5) 
14 (6.8) 
15 (7.3) 
62 (30.1) 
81 (39.3) 
37 (18.0) 
17 (8.3) 
  6 (2.9)  
12 (5.8) 
31 (10.7) 
33 (16.0) 
 
.53 
.04 
.02 
.06 
.05 
.04 
.03 
.05 
.07 
.14 
<.01 
<.01 
<.01 
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Table 7 Baseline characteristics 
 
 Pneumonia 
(n=1306) 
 COPD 
(n=1198) 
Characteristic No Readmission 
(n=1117) 
PAR 
(n=189) 
P-Value 
 
No Readmission 
(n=1025) 
PAR 
(n=173) 
P-Value 
Age (years) 67.7 (4.9) 68.3 (2.8) <.01  63.6 (4.5) 65.3 (2.6) <.01 
Sex, Male 1035 (92.7) 182 (96.3) .07  966 (94.2) 169 (97.7) .04 
Race 
Black 
White 
Other 
 
731 (65.4) 
335 (30.0) 
  51 (4.6) 
 
153 (81.0) 
 25 (13.2) 
 11 (5.8) 
 
 
<.01 
 
  
597 (58.2) 
390 (4.7) 
  38 (37.1) 
 
126 (72.8) 
  42 (24.3) 
    5 (2.9) 
 
 
<.01 
 
Marital status 
Current spouse 
Never married 
Previously married 
 
571 (51.1) 
244 (21.8) 
302 (27.1) 
 
106 (56.1) 
  32 (16.9) 
  51 (27.0) 
 
 
.27 
 
  
579 (56.5) 
201 (19.6) 
245 (23.9) 
 
103 (59.5) 
  41 (23.7) 
  29 (16.8) 
 
 
.09 
 
Primary insurance 
Medicare 
Medicaid 
Private 
Not insured  
 
602 (53.9) 
185 (16.6) 
  89 (8.0) 
241 (21.6) 
 
  91 (48.1) 
  24 (12.7) 
  26 (13.8) 
  48 (25.4) 
 
 
.06 
 
  
535 (52.2) 
157 (15.3) 
  94 (9.2) 
239 (23.3) 
 
103 (59.5) 
  18 (10.4) 
    9 (5.2) 
  43 (24.9) 
 
 
.05 
 
Length of stay (days) 4.9 (5.4) 5.7 (4.2) .03  3.7 (5.1) 4.3 (3.2) .08 
Source of admission 
Direct from home 
Outpatient clinic 
Transfer 
VA NHCU 
VA Domiciliary 
Other 
 
651 (58.3) 
225 (20.1) 
  21 (1.9) 
  59 (5.3) 
  16 (1.4) 
145 (13.0) 
 
114 (60.3) 
  40 (21.2) 
    5 (2.6) 
  14 (7.4) 
    5 (2.6) 
  11 (5.8) 
 
 
 
 
.09 
  
575 (56.1) 
324 (31.6) 
  32 (3.1) 
  62 (6.0) 
  14 (1.5) 
  18 (1.7) 
 
102 (59.0) 
  51 (29.5) 
    3 (1.7) 
    9 (5.2) 
    1 (0.6) 
    7 (4.0) 
 
 
 
 
.36 
Enrollment priority 
1 
2 
3 
4 
5 
6 
7 
8 
 
  74 (6.6) 
141 (12.6) 
219 (19.6) 
115 (10.3) 
341 (30.5) 
172 (15.4) 
  37 (3.3) 
  18 (1.6) 
 
22 (11.6) 
17 (9.0) 
35 (18.5) 
29 (15.3) 
36 (19.0) 
  8 (4.2) 
14 (7.4) 
28 (7.4) 
 
 
 
 
 
<.001 
 
 
 
  
119 (11.6) 
  50 (4.9) 
182 (17.8) 
202 (19.7) 
341 (33.3) 
  22 (2.1) 
  26 (2.5) 
  83 (8.1) 
 
26 (15.0) 
14 (8.1) 
23 (13.3) 
41 (23.7) 
51 (29.5) 
  5 (2.9) 
  7 (4.0) 
  6 (3.5) 
 
 
 
 
 
.01 
 
 
 
Distance to hospital 
Near 
Middle 
Far 
 
692 (62.0) 
421 (37.7) 
    4 (0.4) 
 
127 (67.2) 
  59 (31.2) 
    3 (1.6) 
 
 
.01 
 
  
713 (69.6) 
307 (30.0) 
    5 (0.5) 
 
132 (76.3) 
  37 (21.4) 
    4 (2.3) 
 
 
<.01 
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Table 7 continued 
 
 
 
 
 
 
 
 Pneumonia 
(n=1306) 
 COPD 
(n=1198) 
Characteristic No Readmission 
(n=1117) 
PAR 
(n=189) 
P-Value  No Readmission 
(n=1025) 
PAR 
(n=173) 
P-Value 
Radiation, Yes 10 (0.9) 8 (4.2) <.01  13 (1.3) 9 (5.2) <.01 
Agent Orange, Yes 39 (3.5) 15 (7.9) <.001  64 (6.2) 21 (12.1) <.001 
CAN score 68.3 (4.6) 69.1 (2.8) <.01  70.4 (3.7) 72.7 (2.6) <.01 
No. of past year 
hospitalization 
0 
1–4 
>4 
 
 
485 (43.4) 
593 (53.1) 
  39 (3.5) 
 
 
  56 (29.6) 
114 (60.3) 
  19 (10.1) 
 
 
 
<.01 
 
  
 
526 (51.3) 
447 (43.6) 
  52 (5.1) 
 
 
  33 (19.1) 
117 (67.6) 
  23 (13.3) 
 
 
 
<.001 
 
Comorbidity 
CAD 
Heart failure 
Vascular disease w/c 
Cardiorespiratory  
Pneumonia 
Atrial fibrillation 
Anemia 
Diabetes 
COPD 
Chronic bronchitis 
Malignant neoplasm 
Mental disorder 
Substance abuse 
 
216 (19.3) 
335 (27.7) 
181 (16.2) 
273 (24.4) 
 — 
  66 (5.7) 
  33 (3.0) 
132 (11.8) 
339 (30.3) 
  72 (6.4) 
  31 (3.1) 
106 (9.5) 
138 (12.4) 
 
31 (16.4) 
71 (34.5) 
35 (18.5) 
58 (30.7) 
 — 
14 (7.4) 
10 (5.3) 
35 (18.5) 
69 (36.5) 
  9 (4.8) 
10 (5.3) 
27 (14.3) 
33 (17.5) 
 
.3 
.03 
.4 
.05 
— 
.3 
.09 
.01 
.04 
.4 
.06 
.03 
.04 
  
137 (13.4) 
119 (11.6) 
  82 (8.0) 
  94 (9.2) 
355 (34.6)  
  35 (3.4) 
  13 (1.3) 
288 (28.1) 
— 
402 (39.2) 
156 (15.2) 
221 (21.6) 
269 (26.2) 
 
25 (14.5) 
17 (9.8) 
20 (11.6) 
10 (5.8) 
72 (41.6)  
  8 (4.6) 
  5 (2.9) 
63 (36.4) 
— 
86 (49.7) 
43 (24.9) 
52 (30.1) 
60 (34.7) 
 
.64 
.53 
.14 
.14 
.06 
.43 
.11 
.02 
— 
<.01 
<.001 
.01 
.02 
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Table 8 Variable importance for the baseline PHSF model 
 
 
 
 
 
Attribute Raw score Z-score Sig. 
CAN score 4.87 2.372 .009 
Age 4.53 2.296 .011 
Charlson CI 4.17 2.010 .022 
No. of Past-year hospitalization 4.09 1.816 .035 
Sequence 3.85 1.738 .041 
LOS 3.79 1.658 .049 
CAD 3.36 1.390 .082 
Vascular disease w/c 3.41 1.381 .084 
Admission source 3.21 1.303 .096 
Atrial fibrillation 3.28 1.255 .105 
Priority 2.88 1.068 .143 
Agent Orange 2.52 .961 .168 
Pneumonia 2.75 .930 .176 
Sex 2.19 .869 .194 
Mental disorder 2.66 .815 .207 
Malignant neoplasm 2.53 .762 .223 
Race 1.55 .653 .257 
Radiation 1.43 .564 .286 
Cardiorespiratory disease 1.71 .550 .291 
Insurance 1.21 .483 .314 
Heart failure 1.17 .466 .321 
Diabetes 1.64 .454 .325 
POW .88 .330 .371 
COPD 1.42 .323 .373 
Marital status .80 .283 .389 
All others .63 .197 .422 
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• Model calibration 
We then calibrated the baseline model as follows: 1) we focused only on the 16 most 
important variables found in the baseline model; 2) we imputed missing values based on 
Breiman’s replacement technique; 3) we modified the optimal  cut-off points with regards 
to maximizing the c-statistics (the new cutpoints are 69 years for age, 70 for CAN score, 
and 4.7 for Charlson index, while others remain unchanged); and 4) we altered the class 
weights to 1 on class ‘No-readmission’  and 8 on class ‘PAR’, to adjust for the 
imbalanced prediction errors in the classes. Then we rerun the model with 10,000 trees 
and 4 variables to try at each split.  
Depiction of variable importance for the calibrated model is shown in Table 9. 
Expectedly, the ranking of variables does not change but we achieved better results in 
terms of scores and significance levels. It is noticed that, though Mental disorder and 
Malignant neoplasm are only marginally significant, we decide to keep them in the final 
model since 1) they are both medically significant in contribution to the risk of 
readmission, and 2) they together contribute largely to the model discrimination ability. 
In the calibrated model, the c-statistics jumps to .836; no serious interactions remain 
among variables; and the overall, No-readmission, and PAR error rates become 3.67%, 
2.51%, and 2.64%, respectively. It is remarkable that the calibrated model considerably 
decreases PAR misclassification rate, but at the expense of increasing the overall error 
rate a little bit. We perceive that this tuning in class weights is really appealing for our 
situation because in readmission prediction models, the cost of false negatives (which 
correspond to readmitted patients incorrectly predicted as No-readmission) is usually 
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much higher than the cost of false positives (which correspond to non-readmitted patients 
incorrectly predicted as PAR cases). 
Since the PHSF method takes an ensemble approach of trees, as we mentioned earlier, 
we can obtain an unbiased estimate of PAR probability for each patient. Therefore, it is 
possible to further check the model calibration by evaluating predicted and actual PAR 
rates at different risk deciles. These results appear in Table 10 and Figure 4. 
We note that, both on average and over the whole range of predictions, the predicted 
probability of readmission matches up well with the actual probabilities. Average 
predicted readmission (not shown here) also monotonically increases with growing risk, 
ranging from 8.79% in the lowest decile to 43.75% in the highest, a range of 34.96% in 
total. For the 12% of readmissions that happens between deciles four and five, the PHSF 
model under-predicts by roughly 8.5%. It also over-predicts by about 4%–14% for the 
small number of readmissions (21%) which occur in deciles 6–10.  
 
 
Figure 7 Calibration curve for the PHSF model 
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• Model validation 
Here, we used the calibrated model and studied its internal validity (also called 
reproducibility), based on the same population underlying the sample. To this end, since 
the PHSF does perform bootstrapping internally, we slightly modified the split-sample 
technique for our purposes: we randomly partitioned the sample into 50% training and 50% 
testing sets and redid this 7 times.  
For each partition we ran the PHRF algorithm and obtained the c-statistics. The 
average c-statistics for the seven runs of training sets reached .839 and for the test sets, it 
was .821. Hence, there exists an “optimism” of .018 in the mean AUROCs for the 
training and testing splits, and as a result, the internally-validated (or optimism-corrected) 
c-statistics is estimated as .818. 
To provide more robust evidence of validity, we further conducted external (in fact: 
spatial) validation (also called generalizability) with a new sample of 478 patients 
admitted (with primary diagnosis of HF, AMI, PN, and COPD) in the months of August 
and September 2012. It is noted that we included the same patient factors studied in the 
new sample. The c-statistics in the external sample decreased to .809 (a decrease of .027) 
which is slightly more than results from internal validation (a decrease of .018). However, 
both internal and external validations confirm the superiority of our proposal over the 
current approaches in terms of discrimination power and stability. Nonetheless, we obtain 
greater c-statistics (at least .813) when the PHSF is applied separately on each condition. 
It should also be remarked that with the current sample data, the CMS endorsed model 
can only produce a c-statistics of about .63. 
 
	  	  
68	  
Table 9 Variable importance for the calibrated PHSF model 
 
 
 
 
 
 
 
 
 
 
 
 
Attribute Raw score Z-score Sig. 
CAN score 7.88 3.582 <.0001 
Age 7.32 2.874 .002 
Charlson CI 7.06 2.398 .008 
No. of Past-year hospitalization 7.18 2.324 .010 
Sequence 6.72 2.077 .019 
LOS 6.47 1.957 .025 
CAD 6.24 1.898 .029 
Vascular disease w/c 6.31 1.847 .032 
Admission source 5.95 1.794 .036 
Atrial fibrillation 6.03 1.736 .041 
Priority 5.77 1.705 .044 
Agent Orange 5.62 1.682 .046 
Pneumonia 5.66 1.662 .048 
Sex 5.24 1.656 .049 
Mental disorder 5.39 1.632 .051 
Malignant neoplasm 5.27 1.615 .053 
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Table 10 Calibration by risk decile for the PHSF model 
Risk decile Sample size Predicted PAR Observed PAR O/P ratio 
1 2286 201 183  0.910  
2 1112 149 141  0.946  
3 893 106 118  1.113  
4 481 94 102  1.085  
5 343 79 83  1.051  
6 215 77 74  0.961  
7 138 48 45  0.938  
8 82 31 28  0.903  
9 29 17 15  0.882  
10 16 7 6  0.857  
 
 
Table 11 Performance comparisons of our model over the selected methods 
Method Predictive accuracy measure 
Sensitivity Specificity PPV NPV F-score MCC MSE AUROC 
Our proposal 91.95% 97.65% 86.61% 98.65% .892 .874 .032 .836 
Random Forest 88.43% 97.35% 84.70% 98.07% .865 .843 .039 .802 
SVM 86.16% 97.52% 85.20% 97.70% .857 .833 .041 .775 
Logistic Regression 83.40% 97.21% 83.19% 97.25% .833 .805 .048 .721 
Neural Network 82.39% 97.06% 82.28% 97.08% .823 .794 .051 .704 
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3.4.3   Numerical comparisons 
 
In this section, we evaluate the proposed PHSF method with Logistic Regression 
(LR), Breiman’s Radom Forest (RF), Support Vector Machine (SVM), and Neural 
Network (NN) in terms of predictive measures introduced in previous section (plus mean 
squared error). The models are built and compared with the R version 3.0.2 (RDC Team, 
2005) using packages randomForest (Liaw, Wiener, 2002), e1071 (Dimitriadou et al., 2008), 
glm2 (Marschner, 2011), and also MATLAB neural network toolbox (Demuth, Beale ,1993).  
It is worth mentioning that we used different kernels such as polynomial and radial 
basis function for the SVM method; and for the NN approach, we also tested for two and 
three layers with different numbers of sigmoid hidden neurons and linear output neurons. 
For the pure random forest method, we did the same calibration as with the PHSF, and 
for the logistic regression, we used generalized estimation equation to account for 
clustering at the patient level.  
The comparison results are summarized in Table 11 and Figure 8. As shown, the 
proposal works better than other alternatives in all predictive criteria. The Breiman’s 
random forest approach and SVM produce very close results in this sample but the NN 
approach seems unable to compete with other models having a modest discrimination of 
about 0.7. Not surprisingly, all models predict ‘No-readmission’ cases better than the 
PAR cases. It is of interest that SVM slightly outperforms the RF in terms of precision (.5% 
higher) and true negative rate (.17% higher).  
Furthermore, in the overall spectrum of false positive rates, the proposal assigns a 
higher probability of readmission for a patient with PAR compared to a ‘No-readmission’ 
patient, about 83.6% of the times. Looking at different ROC stairs graphs, we can infer 
that, with a false positive rate between .09 to .25, our PHSF is placed higher than others, 
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but it falls behind the SVM and NN in case of very small rates of false positive. In higher 
false positive rates, we observe that RF and SVM are very similar in discrimination 
ability and they work as well as PHSF beyond .7 false positive rate. However, logistic 
regression turns out to fall short at a type I error rate of .8 to .9. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 ROC curves for different predictive models 
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Chapter IV Conclusion 
 
 
Hospital readmission is disruptive to patients and costly to healthcare systems. About 
one in five Medicare fee-for-service beneficiaries, totaling over 2.3 million patients, are 
re-hospitalized within 30 days after discharge, incurring an annual cost of $17 billion, 
which constitutes near 20% of Medicare’s total payment. However it is reported by the 
Medicare Payment Advisory Commission that about 75% of such readmissions can and 
should be avoided because they are the results of a fragmented healthcare system that 
leaves discharged patients with preventable flaws such as hospital-acquired infections 
and other complications, poor planning for follow-up care transitions, inadequate 
communication of discharge instructions, and failure to reconcile and coordinate 
medications.  
Variations in rate of readmission by medical facility and by geographic region also 
indicate that some hospitals perform better than others at containing readmission rates. In 
addition, effective October 2012, as directed by Patient Protection and Affordable Care 
Act (PPACA), the Centers for Medicare and Medicaid Services (CMS) started to cut 
hospitals’ reimbursement funds that have excess readmission rates for their heart failure, 
myocardial infarction, and pneumonia patients. Hence, reducing unnecessary 
rehospitalization through care transition programs has attracted policymakers and health 
organizations as a way to simultaneously improve quality of care and reduce costs. Yet, 
there is a lack of analytical tools that help understand the care transition dynamics at 
various patients’ health episodes and effectively provide predictions of readmission risks 
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of different patient groups and hospital operation units by using diverse data from 
electronic health records.  
Concentration on reducing unnecessary readmission has never been higher, especially 
with the CMS augmenting the rates of penalties and introducing new waves of diseases 
that will be under scrutiny during next years. In response to this policy shift, hospitals 
and clinicians are become more interested in analytics ways to identify patients at 
elevated risk of avoidable readmission, since such tools can ultimately be used to guide 
more appropriate discharge planning and efficient resource utilization. Although a variety 
of approaches have been proposed to identify patients with higher risk, their potentials 
have been limited mainly because they do not incorporate timing of readmission in their 
prediction and/or they are not accurate enough. 
In this study, we make several contributions to readmission reduction studies. First, 
we address the problem of characterizing avoidable (or unnecessary) readmissions from 
all other types of outcomes. Our algorithm (PAR) is based on administrative data and 
takes a more accurate look at preventability components of rehospitalization compared to 
existing methods. We also suggest using a more comprehensive risk adjustment tool 
(DCG/HCC) in counting avoidable readmissions, as well as getting help from other 
sources of information, like clinic visits between index admission and readmission, in 
assessing the avoidability of readmissions. 
Second, we assert that the government-endorsed 30-day timeframe that is used to 
count readmissions is not “optimal” for chronic conditions such as COPD. Therefore, we 
develop a stochastic model based on Coxian phase-type distribution to analytically 
calculate the optimum cut-point that best stratifies among quickly-readmitted and slowly-
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readmitted COPD patients. We then adopt the new time window in the PAR algorithm to 
adjust for COPD readmissions. 
Third, by combining algorithmic and data models, we put forward a hybrid predictive 
approach that exploits good aspects of classification and timing-based analytics models. 
We then demonstrate the superiority of our model over current solutions with respect to 
various accuracy criteria. Further, to confirm that the high discrimination ability of our 
proposal is irrespective to overfitting, we perform internal and external validation 
practices. Also, unlike some studies in the literature, we do not limit our work to a 
specific disease  or within a specific hospital (Smith et al., 1996), but instead we aggregate 
data from four different VA facilities containing inpatients diagnosed with four different 
conditions.     
Even though our results introduce new aspects of readmission studies, one should pay 
attention to some limitations in interpreting and generalizing them. First, the data used in 
the study is from one region (Veteran Integrated Service Network 11, Veterans In 
Partnership) in the State of Michigan, with a veteran population that is mostly male and 
veteran, and a government-funded care delivery system; hence the results may not be 
identical in other health care systems. Second, the study is limited to administrative data 
(that are regularly available to all health plans) and it does not have laboratory test results 
and vital signs such as hemoglobin or serum level at discharge, which may affect the risk 
of unnecessary readmission.   
In future work, we plan to use our proposal to compare and profile the hospitals on 
their readmission rates using proper risk adjustment for case mix and service mix. The 
approach currently employed by the CMS (and the VHA) is to calculate a ratio of 
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observed to expected outcomes for a given hospital, and evaluate it across the normal 
range of all other hospitals given the same mix. Methods in this context are primarily 
based on models in which the hospital effects on outcome are taken as random. 
Nonetheless, they have been recently argued because 1) they often produce biased 
estimates of outcomes at the provider level; and 2) they cannot prevent confounding 
issues when the patient characteristics are correlated with facility effects (Kalbfleisch, 
Wolfe, 2013). 
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       One of the significant sources of waste in the Unites States health care systems is 
preventable hospital readmission. About 2.3 million Medicare fee-for-service 
beneficiaries are re-hospitalized within 30 days after discharge which incurs an annual 
cost of $17 billion. However, it is reported by the Medicare Payment Advisory 
Commission that about 75% of such readmissions can and should be avoided because 
they are the results of factors such as poor planning for follow up care transitions, 
inadequate communication of discharge instructions, and failure to reconcile and 
coordinate medications. Hence, reducing unnecessary rehospitalization through care 
transition and systems engineering principles has attracted policymakers and health 
organizations as a way to simultaneously improve quality of care and reduce costs.  
In this dissertation we investigated predictive and prescriptive analytics approaches 
for discharge planning and hospital readmission problem. Motivated by the gaps in 
research, we first develop a new readmission metric based on administrative data that can 
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identify potentially avoidable readmissions from all other types of readmission. The 
approach is promising and uses a comprehensive risk adjustment, Diagnostic Cost Group 
Hierarchical Condition Category, to assess the clinical relevance between a readmission 
and its initial hospitalizations. Next, we tackle the difficulties around selecting an 
appropriate readmission time interval by proposing a generic Continuous Time Markov 
Chain (CTMC) approach conceptualizing the movements of patients after discharge. We 
found that cutoff point defining readmission time interval must not depend on the 
instantaneous risk of readmission but rather it has to be based on quality of inpatient or 
outpatient care received. We further assert that the government endorsed 30 day time 
window which has been used for profiling hospitals and public reporting is not 
appropriate for chronic conditions such as chronic obstructive pulmonary disease. Thus, 
we propose a special case of the CTMC method and obtain the “optimal” cut-point that 
best stratifies among inpatient and outpatient care episodes.  
Third, we proposed a novel tree-based prediction method, phase-time survival forest 
(PTSF), for patient risk of readmission that combines good aspects of traditional 
classification methods and timing-based models. The method is simple to implement and 
can be able to (1) model the effect of partially known information (censored 
observations) into the risk of readmission, and (2) directly incorporate patient’s history of 
readmission and risk factors changes over time. The latter property is highly favorable 
especially when repeated measurements of patient factors or recurrent readmissions are 
likely. The basic idea is quite generic and it works by modifying the traditional replicate 
based bootstrap samples to account for correlations among repeated records of a subject. 
We demonstrated the superiority of our model over current solutions with respect to 
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various accuracy and misclassification criteria. Further, to confirm that the high 
discrimination ability of our proposal is irrespective to overfitting, we performed internal 
and external validation with 2011–12 Veterans Health Administration data from 
inpatients hospitalized for heart failure, acute myocardial infarction, pneumonia, or 
chronic obstructive pulmonary disease in the Mid-West facilities. Results indicated 
improved discrimination power compared to the literature (c-statistics greater than 80%) 
and good calibration. 
Overall, the current research outlined a successful multifaceted analytics framework 
that enables medical decision makers to systematically characterize, predict, and reduce 
avoidable readmissions and contribute to patient care quality improvements. 
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